Mycoplasma bovis’e põhjustatud udaranakkuse epidemioloogia piimaveisekarjades by Timonen, Anri Aino Elisa
EPIDEMIOLOGY OF MYCOPLASMA BOVIS 
INTRAMAMMARY INFECTION IN DAIRY HERDS
MYCOPLASMA BOVIS’E PÕHJUSTATUD 
UDARANAKKUSE EPIDEMIOLOOGIA 
PIIMAVEISEKARJADES
ANRI AINO ELISA TIMONEN
A Thesis
applying for the degree of Doctor of Philosophy in Veterinary Science
Väitekiri






















































Doctoral Theses of  the
Estonian University of  Life Sciences

EPIDEMIOLOGY OF MYCOPLASMA BOVIS 
INTRAMAMMARY INFECTION IN DAIRY HERDS
MYCOPLASMA BOVIS’E PÕHJUSTATUD UDARANAKKUSE 
EPIDEMIOLOOGIA PIIMAVEISEKARJADES
ANRI AINO ELISA TIMONEN
A Thesis
for applying for the degree of  Doctor of  Philosophy
in Veterinary Science
Väitekiri
filosoofiadoktori kraadi taotlemiseks loomaarstiteaduse erialal
Tartu 2020
Institute of  Veterinary Medicine and Animal Sciences,
Estonian University of  Life Sciences
According to verdict N° 2 of  April 8, 2020, the Doctoral Committee of  
Veterinary and Food Science of  Estonian University of  Life Sciences 
has accepted the thesis for the defence of  the degree of  Doctor of  
Philosophy in Veterinary Science.
Opponent: Prof. Joachim Frey
  Institute of  Veterinary Bacteriology
  Vetsuisse Faculty, University of  Bern, Switzerland
Supervisors: Assoc. Prof. Piret Kalmus, DVM, PhD
  Chair of  Clinical Veterinary Medicine
  Institute of  Veterinary Medicine and Animal Sciences
  Estonian University of  Life Sciences
  Assoc. Prof. Kerli Mõtus, DVM, PhD
  Chair of  Clinical Veterinary Medicine
  Institute of  Veterinary Medicine and Animal Sciences
  Estonian University of  Life Sciences
Defence of  the thesis:
International video conference on BBB web room https://videosild.
emu.ee/b/and-anf-kdy on June 11, 2020, at 10:00.
The publication of  this dissertation is granted by the Estonian University 
of  Life Sciences
Language Editors:
Elsevier B.V. (English)
Mrs. Urve Ansip (Estonian)
© Anri Aino Elisa Timonen, 2020
ISSN – 2382-7076
ISBN – 978-9949-698-23-3 (printed)
ISBN – 978-9949-698-24-0 (pdf)
If  you can dream it, you can do it.
- Walt Disney
CONTENTS
LIST OF ORIGINAL PUBLICATIONS .................................................9
ABBREVIATIONS .....................................................................................10
1. INTRODUCTION .................................................................................11
2. REVIEW OF THE LITERATURE ....................................................13
2.1. An overview of  the Mycoplasma bovis infections ...........................13
2.1.1. Characterisation of  Mycoplasma bovis ......................................13
2.1.2. Host immune response in Mycoplasma bovis infections ........14
2.1.3. Mycoplasma bovis-associated diseases .......................................16
2.1.4. Transmission of  Mycoplasma bovis infections .........................18
2.1.5. Diagnosis of  Mycoplasma bovis infections ...............................19
2.1.6. Prevalence of  Mycoplasma bovis ................................................22
2.1.6.1. Prevalence of  Mycoplasma bovis in milk ...........................22
2.1.6.2. Seroprevalence and prevalence of  respiratory 
manifestation of  Mycoplasma bovis .................................................24
2.1.7. Treatment of  Mycoplasma bovis infections ..............................25
2.1.8. Control measures for Mycoplasma bovis ...................................26
3. AIMS OF THE STUDY ........................................................................28
4. MATERIALS AND METHODS ........................................................29
4.1. Study design ......................................................................................29
4.2. Sample collection and handling (I-III) ..........................................32
4.2.1. Collection of  cow composite milk samples (I-II) ................32
4.2.2. Collection of  colostrum samples (II) ....................................32
4.2.3. Collection of  cow clinical mastitis milk samples (II) ..........33
4.2.4. Collection of  calf  respiratory samples (II) ...........................33
4.2.5. Pooling of  milk samples (II) ...................................................34
4.2.6. Collection of  udder quarter milk samples before and 
after dry period (III) ............................................................................35
4.3. Laboratory analytical methods .......................................................35
4.3.1. Analysis of  cow composite milk samples (I) ........................35
4.3.2. Quantitative polymerase chain reaction method (I-III) ......35
4.3.3. Microbiolocigal isolation of  Mycoplasma bovis (II) ................36
4.3.4. Core genome multilocus sequence typing (II)......................36
4.3.5. Determination of  milk haptoglobin (III) ..............................37
4.4. Statistical analysis (I-III) ..................................................................37
5. RESULTS ..................................................................................................41
5.1. The prevalence of  Mycoplasma bovis intramammary infection ....41
5.1.1. Within-herd prevalence of  Mycoplasma bovis 
intramammary infection (I and II) ....................................................41
5.1.2. The prevalence of  Mycoplasma bovis in cow colostrum 
and clinical mastitis samples (II) .......................................................43
5.2. Associations between the Mycoplasma bovis IMI and cow 
production indices (I) ..............................................................................44
5.3. Associations between the milk haptoglobin concentration 
and the presence of  Mycoplasma bovis in cow udder quarter milk 
samples (III) ..............................................................................................47
5.4. Comparison of  genomes of  Mycoplasma bovis isolates from 
calf  respiratory and cow clinical mastitis samples (II) .......................47
5.5. Elimination of  Mycoplasma bovis during the dry period (III) ......49
6. DISCUSSION ..........................................................................................50
6.1. The within-herd prevalence of  Mycoplasma bovis 
intramammary infection (I and II) ........................................................50
6.2. The prevalence of  Mycoplasma bovis in cow colostrum and 
clinical mastitis samples (II) ...................................................................51
6.3. Estimation of  intramammary Mycoplasma bovis within-herd 
prevalence from cow composite and pooled milk samples with 
qPCR (I and II) ........................................................................................51
6.4. The associations between cow Mycoplasma bovis 
intramammary infection and milk yield and milk composition (I) ..53
6.5. Inflammatory response in the Mycoplasma bovis infected 
udder quarters before and after dry period (III) .................................53
6.6. Comparison of  Mycoplasma bovis strains (II) .................................54
6.7. Elimination of  Mycoplasma bovis during the dry period (III) ......55
7. CONCLUSIONS ....................................................................................56
8. REFERENCES .......................................................................................58






LIST OF ORIGINAL PUBLICATIONS
The thesis is based on three original publications (I-III). The articles are 
referred in the text using Roman numerical.
I Timonen, A.A.E, Katholm, J., Petersen, A., Mõtus, K., Kalmus, 
P. 2017. Within-herd prevalence of  intramammary infection 
caused by Mycoplasma bovis and associations between cow udder 
health, milk yield, and composition. Journal of  Dairy Science, 
100, 6554−6561.
II Timonen, A.A.E, Autio, T., Pohjanvirta, T., Häkkinen, L., 
Katholm, J., Petersen, A., Mõtus K., Kalmus, P. 2020. Dynamics 
of  the within-herd prevalence of  Mycoplasma bovis intramammary 
infection in endemically infected dairy herds. Veterinary 
Microbiology. Accepted 5 February 2020.
III Timonen, A.A.E., Katholm, J., Petersen, A., Orro, T., Mõtus, 
K., Kalmus, P. 2018. Elimination of  selected mastitis pathogens 
during the dry period. Journal of  Dairy Science, 101, 9332–9338.
The contribution of  the authors to the research papers
Paper Original idea, study design Data collection Data analysis
Preparation of  
manuscript
I AT, KM, PK AT, PK AT, AP, KM All authors
II AT, KM, PK AT, KM, PK AT, LH, AP, KM, TA All authors
III AT, KM, PK AT, PK AT, AP, KM, TO All authors
AT – Anri A.E. Timonen, JK – Jörgen Katholm, AP – Anders Petersen, KM – 
Kerli Mõtus, TO – Toomas Orro, PK – Piret Kalmus, TA – Tiina Autio, TP – Tarja 
Pohjanvirta, LH – Liidia Häkkinen
10
ABBREVIATIONS
APP acute phase protein
APR acute phase response
BRD bovine respiratory disease
BTM bulk tank milk
CFU colony forming units
cg-MLST core genome multilocus sequence typing
CI confidence interval/ credibility interval
CMS composite milk sample
DIM days in milk
DNA deoxyribonucleic acid
ELISA enzyme-linked immunosorbent assay
Hp  haptoglobin
IMI intramammary infection
M. bovis Mycoplasma bovis
MALDI-TOF matrix-assisted laser desorption ionization-time of  flight 
mass spectrometry
MIC minimal inhibitory concentration
ODC optical density coefficient
PCR polymerase chain reaction
rt-PCR real-time polymerase chain reaction
qPCR quantitative polymerase chain reaction
SCC somatic cell count
Staph. aureus Staphylococcus aureus
Strep. agalactiae Streptococcus agalactiae
Strep. uberis Streptococcus uberis
TBL tracheobronchial lavage
VSP variable surface lipoprotein
11
1. INTRODUCTION
Mastitis, an inflammation of  the mammary gland, is the most common 
disease affecting dairy cattle worldwide. Mycoplasma infections were first 
identified in naturally occurring mastitis cases in cattle in the 1960s 
(Jain et al., 1969) and in calves with arthritis in the 1970s (Pfützner and 
Schimmel, 1979). Mycoplasma (M.) bovis is an emerging udder pathogen 
causing intramammary infection (IMI), which commonly leads to 
mastitis (Gonzalez et al., 1992; Nicholas and Ayling, 2003). In addition to 
mastitis in dairy cows, M. bovis causes respiratory disease and arthritis in 
calves (Stalheim and Page, 1975; Nicholas et al., 2002). M. bovis infection 
seems also to lower the weight gain of  calves (Nicholas et al., 2002), 
affecting calf  welfare.
The effect of  M. bovis infections to the cattle industry is negative both 
economically and considering animal welfare. M. bovis-associated IMI 
causes economic losses to the dairy industry due to lower milk yield and 
decreased milk quality (Al-Farha et al., 2017). Compared to other major 
mastitis pathogens, lower 305-day mature equivalent milk production 
was detected in cows with Mycoplasma mastitis, leading to an estimated 
economic loss of  $451.63 per lactation (Wilson et al., 1997). Additionally, 
somatic cell count (SCC) is usually higher in cows with M. bovis IMI (Fox, 
2012), decreasing milk quality. Undesirably, M. bovis-seropositive heifers 
have higher risk for undesired early departure from the herd before first 
calving (Petersen et al., 2019).
In recent decades, new molecular diagnostic methods have been 
established. The polymerase chain reaction (PCR) method has replaced 
the traditional bacteriological cultivation in diagnosis of  bovine mastitis 
due to the high sensitivity and speediness of  the test (Koskinen et al., 
2010; Hiitiö et al., 2015). Bacteriology of  genus Mycoplasma is slow and has 
low sensitivity (González and Wilson, 2002; Fox et al., 2005). Molecular 
diagnostic methods have made the diagnosis of  M. bovis infections 
easier, probably increasing the prevalence of  M. bovis IMI worldwide 
(Fox et al., 2005). Rapid diagnosis of  M. bovis IMI is essential to avoid the 
economic losses together with avoiding the spread of  the disease within 
and between dairy herds.
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In 2018, the Estonian dairy cow population was 85,200 dairy cows, of  
which 81,821 (96.0%) dairy cows belonged to a voluntary basis milk 
recording system. Off  all dairy herds, 49.1% of  the dairy herds had 
≥50 cows in the herd. An average 305-day milk yield per cow was 9,785 
kg in 2018 (Estonian Livestock Performance Recording Ltd., 2019). 
Although the proportion of  large dairy herds is moderate, a relatively 
large proportion of  the Estonian dairy cows (32.8%) are housed in herds 
with ≥100 dairy cows (Estonian Livestock Performance Recording 
Ltd., 2019). M. bovis IMI is more prevalent in large dairy herds (USDA-
APHIS, 2008). Previously, no prevalence or epidemiologic studies have 
studied M. bovis IMI in Estonia. However, the Estonian dairy population 
serves as an adequate study population for endemic M. bovis IMI studies 
because the pathogen has been identified in Estonian dairy operations 
annually (Estonian Veterinary and Food laboratory, 2018), and no official 
control schemes are established for the disease. 
Despite the long history and worldwide presence of  M. bovis infections 
in cattle, the epidemiology of  M. bovis infections in dairy herds is still 
not fully understood. Similarly, the within-herd prevalence of  M. bovis 
IMI is not widely studied, although knowledge about the dynamics of  
the within-herd prevalence of  M. bovis IMI would benefit the disease 
surveillance.
This dissertation focuses on the prevalence and epidemiology of  M. bovis 
mastitis in Estonian dairy herds. In Study I, the within-herd prevalence 
of  M. bovis IMI was evaluated in one dairy herd, and associations 
between M. bovis IMI and cow milk yield and milk quality were studied. 
In Study II, the M. bovis IMI within-herd prevalence was evaluated in 
four dairy herds with repeated cross-sectional study design. Additionally, 
cow clinical mastitis and calf  respiratory isolates of  M. bovis were 
characterised in Study II. The elimination of  M. bovis IMI during the 
dry period and associations with milk haptoglobin concentration were 
evaluated in Study III.
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2. REVIEW OF THE LITERATURE
2.1. An overview of  the Mycoplasma bovis infections
2.1.1. Characterisation of  Mycoplasma bovis
Mycoplasma spp. cause bovine mycoplasmosis, leading to multiple types 
of  infections in cattle (Bürki et al., 2015). Several Mycoplasma species are 
associated with cattle infections, the most dominant species being M. 
bovis (Gioia et al., 2016). Other less prevalent Mycoplasma species causing 
infections in cattle include for example M. bovigenitalium, M. californicum, 
M. bovirhinis, M. alkalescens and M. dispar (Nicholas and Ayling, 2003; Fox, 
2012; Gioia et al., 2016).
Mycoplasma belong to the Mollicute genus bacteria, which lack a cell wall 
and are the smallest self-replicating bacteria with a parasitic way of  life 
(Razin, 1997; Rosengarten et al., 2000). Mycoplasma cells have three main 
cell organelles: the cell membrane, ribosomes, and circular DNA. The 
cells are spherical with a diameter of  0.3–0.8 µm (Razin and Hayflick, 
2010). Fatty acids and sterols as nutrients are necessary for Mycoplasma 
cells (Razin and Hayflick, 2010). Demanding growth requirements and 
the simple attribute of  the Mycoplasma cells enables the adaptation of  
bacteria with the host organism (Fox, 2012). Sunlight and desiccation are 
injurious to Mycoplasma cells. Despite this, M. bovis may survive in cool 
and humid conditions for long periods (Pfützner, 1984), probably due to 
biofilm formation (McAuliffe et al., 2006).
In general, pathogenic characteristics of  Mycoplasma include adherence 
and internalization to host cells, immunomodulatory characteristics and 
ability to colonise host tissue (Maunsell et al., 2011; Fox, 2012). All these 
pathogenic characteristics contribute to evade the host immune response 
and cause a chronic manifestation of  M. bovis infection (Buchenau et al., 
2010; Fox, 2012). Additionally, biofilm formation by M. bovis enables the 
pathogen to survive in the environment and inside the host (McAuliffe 
et al., 2006).
During Mycoplasma infection, adhesion to host cells is usually the first 
phenomenon (Rottem, 2003). Adhesion is necessary for successful 
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colonisation, which is driven by avoidance of  physical removal through 
mucociliary clearance, and for acquisition of  nutrients (Rosengarten 
et al., 2000). Membrane proteins of  the Mycoplasma cell form the main 
interface with the host and enable the adherence to host cells (Sachse et 
al., 1996; Lysnyansky et al., 1999; Buchenau et al., 2010). Variable surface 
lipoproteins (VSP) and other types of  adhesions are involved in the 
adherence of  M. bovis to the host cells (Sachse et al., 1996; Thomas et al., 
2003; Fox, 2012). The adherence of  M. bovis to host cells may depend 
on the strain of  the pathogen. Virulent M. bovis strains have higher 
adherence rates compared to less or non-virulent strains (Thomas et 
al., 2003). After adherence, M. bovis produces phospholipases, hydrogen 
peroxide and superoxide radicals, damaging the host cells (Khan et al., 
2005; Bürki et al., 2015).
2.1.2. Host immune response in Mycoplasma bovis infections
VSP on Mycoplasma cell membrane are produced after exposure to 
host antibodies being therefore antibody-specific and providing a large 
antigenic variation (Buchenau et al., 2010; Browning et al., 2011). There 
are multiple genes coding the VSP (Lysnyansky et al., 1996, 1999) and 
several VSP may coexist on the cell membrane leading to specific 
structural and antigenic features of  M. bovis (Lysnyansky et al., 1999; 
Bürki et al., 2015). Hence, the variation in antigenic heterogeneity of  
M. bovis is independent of  the geographical origin and type of  organ or 
disease produced by a single strain (Rosengarten et al., 1994).
Host cell invasion after adherence allows Mycoplasma to evade the 
host immune response (Rosengarten et al., 2000). M. bovis has been 
detected from peripheral blood mononuclear cells, erythrocytes (van 
der Merwe et al., 2010) and macrophages and neutrophils, whereas M. 
bovis antigen has been detected in lymph nodes and occasionally from 
bronchiolar epithelial cells (Adegboye et al., 1995; Rodriguez et al., 1996; 
Kleinschmidt et al., 2013). However, M. bovis has not been detected in 
alveolar epithelial cells of  the mammary gland (Stanarius et al., 1981, 
reviewed by Bürki et al., 2015). Intracellular persistence of  M. bovis in 
phagocytes is presumably attributed to an alteration of  the process of  
phagocytosis after engulfment (Kleinschmidt et al., 2013). Along with 
avoiding the host immune response, invading host cells enable M. bovis 
to reach multiple organ systems and body sites of  the diseased animal, 
cause chronic infections and impair the antibiotic treatment of  M. bovis 
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infections (Rosengarten et al., 2000; Bürki et al., 2015). Jain et al. (1969) 
identified Mycoplasma from blood of  two cows experimenttally infected 
with Mycoplasma originating from clinical mastitis cases. 
The modulation of  the host’s immune response is operated mainly 
through altered immune cell and cytokine functions (Bürki et al., 2015) 
leading to prolonged survival and systemic dissemination of  M. bovis 
in host organism (Mulongo et al., 2014). Both immunosuppression and 
stimulation are described. Stimulation of  the immune system is suspected 
to occur through macrophages, T cells or complement activation together 
with the presence of  cytokines, leading to upregulated immune response 
(Vanden Bush and Rosenbusch, 2003; Kauf  et al., 2007). On the contrary, 
expression of  anti-inflammatory cytokines and chemokines, such as 
interleukin (IL)-10, together with suppression of  pro-inflammatory 
cytokines, such interferon (IFN)-γ and tumour necrosis factor (TNF)-α, 
production are considered the reasons for immunesuppression 
(Mulongo et al., 2014). Other explanations for immunosuppression 
might be a downregulation of  lymphocyte proliferation, formation of  
putative mycoplasmal lympho-inhibitory protein or interference of  
lympho-proliferative response to phytoagglutinin (Thomas et al., 1990; 
Vanden Bush and Rosenbusch; 2003; van der Merwe et al., 2010). Studies 
about M. bovis-induced apoptosis of  peripheral blood mononuclear 
cells are controversial. Some studies describe induction of  apoptosis in 
lymphocytes by M. bovis in vitro (Vanden Bush and Rosenbusch, 2002), 
and others result in delayed apoptosis in bovine monocytes infected 
with M. bovis (Mulongo et al., 2014). Additionally, M. bovis might obtund 
the host immune response by binding to neutrophils and inhibiting their 
oxidative burst (Thomas et al., 1991) and suppress immune response in 
bovine mammary epithelial cells (Gondaira et al., 2018).
After injury, acute phase response (APR) is triggered by cytokines, 
messenger proteins between active site of  injury and hepatocytes. 
During APR, serum concentrations of  acute phase proteins (APP), 
which are mainly produced in hepatocytes, change intrinsically (Petersen 
et al., 2004). In addition to injuries, both inflammatory and infectious 
processes may trigger the APR, increasing concentrations of  APP in 
serum (Hiss et al., 2004; Thielen et al., 2007). Bovine haptoglobin (Hp) 
and serum amyloid A (SAA) are APPs serving as non-specific indicators 
of  inflammatory response (Petersen et al., 2004). Although APR is 
commonly thought to be part of  a general defence mechanism toward 
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tissue injury (Petersen et al., 2004), stress is also associated with increased 
serum APP concentrations (Alsemgeest et al., 1995). Hypothetically, 
serum APP levels can be used as markers of  herd health (Gånheim et 
al., 2007) and sub-clinical inflammation in cattle (Karreman et al., 2000). 
An increase in serum concentration of  APP is associated with both 
viral respiratory pathogens, such as bovine respiratory syncytial virus 
(Heegaard et al., 2000; Orro et al., 2011) and bovine virus diarrhoea virus 
(Gånheim et al., 2003) and bacterial pathogens, including P. multocida 
(Nikunen et al., 2007) and M. haemolytica (Gånheim et al., 2003) in naturally 
occurring respiratory infections and experimental trials. Additionally, 
local production of  Hp in mammary glands occurs during IMI as Hp 
is released from the damaged epithelial cells and neutrophils (Hiss et 
al., 2004). However, associations between M. bovis respiratory disease or 
IMI and serum or milk APP concentrations have not been previously 
studied.
Natural M. bovis infections, such as mastitis, arthritis and pneumonia, 
alter antibody response in the organism (Hazelton et al., 2018a; Petersen 
et al., 2018). The seroconversion is thought to take up to one month 
(Foster et al., 2009), while vaccination causing seroconversion occurs 
in two to three weeks (Nicholas et al., 2002). However, the duration 
of  elevated antibody titres after natural exposure to M. bovis has not 
been well characterised, even though Byrne et al. (2000) suspected that 
antibodies stay elevated for several months after M. bovis outbreak. Both 
Hazelton et al. (2018a) and Petersen et al. (2018) state that antibody 
response after M. bovis infection may differ between individual cows, with 
some seroconverting and others not. M. bovis mastitis causes elevated 
antibody concentrations in milk and serum (Petersen et al., 2018). On 
the contrary, antibody levels in milk in cows having M. bovis infections 
other than mastitis are not elevated (Petersen et al., 2018). Hence, the 
antibody response in milk after M. bovis mastitis is probably local (Byrne 
et al., 2000).
2.1.3. Mycoplasma bovis-associated diseases
Mycoplasmoses are slowly progressive chronic infections (Rosengarten 
et al., 2000). M. bovis causes most often IMI in adult cattle, leading to 
subclinical or clinical mastitis (González and Wilson, 2003) and bovine 
respiratory disease (BRD) and arthritis in cattle of  all ages (Stalheim and 
Page, 1975; Nicholas et al., 2002). Additionally, M. bovis may occasionally 
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cause abortions (Doig, 1981), meningitis (Stipkovits et al., 1993), otitis 
media (Francoz et al., 2004; Foster et al., 2009), keratoconjunctivitis 
(Alberti et al., 2006) and subcutaneous abscesses (Kinde et al., 1993). 
Pathogens have also been identified from post-surgical seromas (Gille 
et al., 2016).
The course of  M. bovis mastitis in dairy herds is usually endemic 
subclinical disease, although severe clinical mastitis outbreaks may also 
occur (Pothmann et al., 2015). M. bovis IMI may occur without elevated 
milk somatic cell count (SCC) (Pinho et al., 2013). Pinho et al. (2013) 
found that in three cows having negative California Mastitis test result, 
udder quarter milk samples (n = 4) were M. bovis-positive. In a study 
made by Kauf  et al. (2007), SCC increased 66 hours after infection, 
and during a ten-day study period, SCC stayed elevated in dairy cows 
experimentally infected with M. bovis. The maximum SCC in milk was 
120 million cells/ml (Kauf  et al., 2007). Clinical M. bovis mastitis does 
not induce specific clinical signs. In general, several udder quarters are 
infected, milk yield decreases dramatically, the mammary gland might 
be swollen, and milk secretions might be mildly abnormal to purulent 
with brownish colour. Severe systemic signs are usually absent as febrile 
response is not induced by M. bovis IMI (Kauf  et al., 2007). Clinical M. 
bovis mastitis may persist for several weeks. Mastitis caused by M. bovis is 
also detected in dry cows (Otter et al., 2015).
M. bovis may occur in BRD complex, usually in calves (Rosendal 
and Martin, 1986; Schibrowski et al., 2018). In naturally infected 
cattle with pneumonia, M. bovis is commonly detected with other 
microorganisms (Shahriar et al., 2002; Booker et al., 2008), mainly 
with bacterial pathogens Mannheimia haemolytica, Histophilus somni and 
Pasteurella multocida (Byrne et al., 2001; Griffin et al., 2010). Natural M. 
bovis pneumonia is characterised with exudative bronchopneumonia 
with possible coagulative necrosis (Rodriguez et al., 1996). Radaelli et 
al. (2008) associated a high number of  intralesional organisms with a 
severe necrosuppurative bronchopneumonia or fibrinonecrotising 
pneumonia, whereas a low number of  organisms was associated with 
mild catarrhal bronchointerstitial pneumonia. Clinical signs in M. bovis-
induced respiretory disease are non-specific, including fever, tachypnoea, 
dyspnoea and decreased appetite. Coughing and nasal discharge may 
also occur (Stipkovits et al., 2000). Clinical signs may be more severe if  
coinfection of  M. bovis and other respiratory pathogens exists. 
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Both M. bovis mastitis and respiratory disease may occur together with 
other manifestations of  disease. Arthritis and respiratory disease may 
occur together with M. bovis mastitis (Pothmann et al., 2015). Furthermore, 
M. bovis pneumonia might be accompanied by otitis media, arthritis or 
both (Mahmood et al., 2017). 
2.1.4. Transmission of Mycoplasma bovis infections
Introduction of  M. bovis infection to the dairy herd is usually conducted 
by importing subclinically infected animals to the herd (Fox et al. 2003; 
Gonzalez and Wilson, 2003; Filioussis et al. 2007; Fox 2012). More 
recently, contaminated semen used for artificial insemination has been 
proven to be a source of  M. bovis infection to dairy herds in Finnish study 
by Haapala et al. (2018). Additionally, Hazelton et al. (2018b) identified 
an increase from 9 to 46% in the seroprevalence of  M. bovis among 
bulls introduced to M. bovis-positive dairy herds for the breeding period. 
Four bulls had M. bovis culture-positive semen samples (Hazelton et al., 
2018b). Researchers concluded that infected bulls could be potential 
transmitters of  M. bovis infection into a naïve dairy herd (Hazelton et al., 
2018b). 
M. bovis is considered to belong to a group of  contagious mastitis 
pathogens together with Staphylococcus (Staph.) aureus and Streptococcus 
(Strep.) agalactiae (Royster and Wagner, 2015). Contagious udder pathogens 
can attach to the udder epithelia (Frost et al. 1977; Royster and Wagner, 
2015). Cows with M. bovis IMI shed bacteria with milk (Jasper, 1977). 
Hence, transmission of  M. bovis IMI between diseased and healthy cows 
may occur during milking (Ruegg and Erskine, 2015). Milking machine, 
hands of  the milk maid and cleaning towels may all serve as vectors 
for transmission of  bacteria, especially if  cows with mastitis are milked 
together with healthy cows (Punyapornwithaya et al., 2011; Keefe, 2012).
As animals also excrete M. bovis with other secretions, transmission of  
pathogens can also occur through contaminated feed, water or bedding 
material (Fox et al., 2005; Justice-Allen et al., 2010; Maunsell et al., 2011). 
Transmission between cows and calves is commonly thought to occur 
via contaminated milk (Butler et al., 2000). M. bovis has also been isolated 
from vaginal secretions of  cows at calving (Feenstra et al., 1991) and 
from foetuses and placenta (Hassan and Dokhan, 2004; Hermeyer et al., 
2012). Hence, vertical transmission of  M. bovis infection may also occur.
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2.1.5. Diagnosis of  Mycoplasma bovis infections
Traditionally, microbiological methods are used to identify bacteria from 
pathologic material, such as milk or respiratory secretions, by cultivating 
material on specific agar plates. On-farm culture methods are developed 
to detect udder pathogens rapidly and with high sensitivity (Lago et al., 
2011; Cameron et al., 2014). However, Mycoplasma cannot be cultivated with 
traditional agar plates detecting other common pathogens. A modified 
Hayflick agar plate is needed for cultivation of  Mycoplasma (Dorman et 
al., 1983). Plates are incubated for seven to ten days under environmental 
conditions of  35 °C and 10% CO2 concentration for culture growth 
(Dorman et al., 1983; Maunsell et al., 2011; Ruegg and Erskine, 2015). A 
long incubation period is non-economic and delays the diagnosis (Fox et 
al., 2005; Boonyayatra et al., 2012). Additionally, cultivation of  Mycoplasma 
has low accuracy, probably due to the extreme nutrient demands and 
difficulties of  preventing other bacteria from growing on the Hayflick 
plates (Gonzalez and Wilson, 2003; Maunsell et al., 2011). Low bacterial 
concentration due to intermittent shedding of  M. bovis may cause false-
negative cultivation results (González and Wilson, 2002). In a study 
by Biddle et al. (2003), cows with Mycoplasma mastitis shed bacteria in 
different amounts. Only 39% of  the cows shed Mycoplasma with milk 
in an amount of  ≥100 CFU/ml. Furthermore, freezing of  samples for 
storage may influence the recovery of  Mycoplasma, leading to no growth 
in cultivation (Biddle et al., 2004; Boonyayatra et al., 2010; Olde Riekerink 
et al., 2010; Ruegg and Erskine, 2015). However, freezer storage time 
and number of  freeze-thaw cycles influences the recovery of  Mycoplasma 
during freezing. Single and double freeze-thaw cycles have reduced the 
M. bovis concentration by 1 and 1.5 log in colostrum, while 14-week 
storage time at –18 °C did not significantly decrease the survival of  M. 
bovis compared to one-week storage time (Gille et al., 2018a). Bacterial 
cultivation detects only the genus Mycoplasma. Further identification of  
Mycoplasma species should be done with molecular methods (Fox et al., 
2005). 
Development of  matrix-assisted laser desorption ionisation-time of  
flight mass spectrometry (MALDI-TOF) has emerged as a new, rapid 
and accurate technology for species and specific bacterial characteristic 
identification from bacterial colonies (Firacative et al., 2012; Pereyre 
et al., 2013; Lasch et al., 2015). Mycoplasma VSP are detected with 
MALDI-TOF (Vanden Bush and Rosenbusch, 2004; Sun et al., 2014). 
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Additionally, Pereyre et al. (2013) correctly identified 95 to 98% of  
ruminant Mycoplasma species and were able to differentiate M. bovis from 
M. agalactiae using MALDI-TOF. However, only bacteria belonging to 
the reference database can be identified using MALDI-TOF.
The polymerase chain reaction (PCR) method is commonly used in 
pathogen detection. Advantages of  the PCR method are the sensitivity 
and fast analysis of  the pathogenic material together with the ability 
of  the method to depict bacteria at species level (Hiitiö et al., 2015). 
Commercial test kits, such as PathoProof  PCR assays (ThermoFisher 
Scientific) or Mastitis 4 (DNA Diagnostic A/S), include DNA detection 
of  genus Mycoplasma and different Mycoplasma species, depending on the 
test kit. Milk or respiratory secretions can be analysed for M. bovis with 
PCR without previous cultivation of  bacteria (Fox et al., 2005; Cornelissen 
et al., 2017). Boonyayatra et al. (2012) identified an overall accuracy of  
98.51% for the real-time PCR (rt-PCR) method for Mycoplasma analysing 
milk and organ tissues. They also identified Mycoplasma with rt-PCR 
directly from milk with bacterial concentrations of  10–30 CFU/ml 
(Boonyayatra et al., 2012). Previously, DNA of  Mycoplasma has been 
detected with rt-PCR from milk with bacterial concentration of  ≤100 
CFU/ml (Sachse et al., 2010). The sensitivity of  the PCR method 
depends on sample type and concentration of  bacterial DNA in the 
sample (de Carvalho et al., 2015). Additionally, highly sensitive PCR also 
detects DNA of  bacteria already killed by the host organism, which 
may cause clinically irrelevant treatment decisions to be made (Fox et al., 
2005; Hiitiö et al., 2015) and only DNA of  bacteria included to the test 
kit are detected (Hiitiö et al., 2015). 
Antibodies against Mycoplasma can be detected by the enzyme-
linked immunosorbent assay (ELISA) method. Mycoplasma antibody 
concentration can be measured from both milk and serum (Thomas 
et al., 1987; Byrne et al., 2000). A high specificity for detection of  M. 
bovis antibodies is described (Byrne et al., 2000). Even though there are 
multiple pathogenic Mycoplasma species, ELISA test cannot distinguish 
between different species (Fox et al., 2005). 
Both herd- and animal-level diagnosis are used in diagnostic protocols 
to detect M. bovis infections in dairy herds. For herd-level diagnosis and 
surveillance of  M. bovis, bulk milk testing is usually performed. M. bovis 
antibodies (Nielsen et al., 2015; Petersen et al., 2016; Parker et al., 2017), 
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DNA of  M. bovis (Pinho et al., 2013; Bauman et al., 2018) or viable bacteria 
(Olde Riekerink et al., 2006; McDonald et al., 2009) can be identified from 
bulk milk, indicating the presence or previous exposure of  M. bovis in the 
herd. In general, a positive bulk milk culture for Mycoplasma is thought to 
indicate at least one cow shedding the bacteria (Biddle et al., 2003). Both 
bulk milk ELISA and PCR are sensitive to identify M. bovis-positive dairy 
herds, especially when focusing on positivity of  dairy cows. Nielsen et 
al. (2015) identified a sensitivity of  43.5% and specificity of  99.6% of  
bulk milk ELISA for detection of  M. bovis antibodies using the cut-off  
value 50% optical density coefficient (ODC%). Petersen et al. (2016) 
associated a higher cow seroprevalence of  M. bovis with increased bulk 
milk ODC%, while the seroprevalence of  M. bovis-positive youngstock 
did not correlate with the bulk milk ODC%. Parker et al. (2017) were 
able to detect M. bovis antibodies from bulk milk zero to eight months 
after M. bovis outbreak in herds. A sensitivity of  76.7% of  PCR analysis 
of  Mycoplasma from bulk milk was identified in a study by Justice-Allen 
et al. (2011). Additionally, Parker et al. (2017b) found that bulk milk 
samples had more samples identified as positive by multiplex probe PCR 
(n = 11) than by culture (n = 4).
M. bovis-positive bulk milk indicates only presence of  the pathogen in 
the dairy herd. The within-herd prevalence of  M. bovis IMI cannot be 
estimated based on positive bulk milk, and diseased animals should be 
identified by testing (Fox et al., 2005) either individually or by groups. 
Separate testing should be performed to identify the presence and 
circulation of  M. bovis among youngstock. 
Estimation of  the within-herd prevalence of  M. bovis IMI is complicated 
(Fox, 2012), and it is usually evaluated by analysing cow composite milk 
samples (CMS) (Ghadersohi et al., 1999; Filioussis et al., 2007; Murai et 
al., 2014). Murai et al. (2014) discovered the most cost-effective strategy 
to identify M. bovis IMI-positive dairy cows to be two-staged culture 
strategy, in which pools of  five cows’ CMS were first cultured, and 
then individual cow CMS that constituted positive pools was cultured. 
Sensitivity of  the strategy was 73.5% (Murai et al., 2014). Cow CMS or 
udder quarter milk samples may also be analysed with PCR to identify 
M. bovis-positive cows or quarters. 
Serological testing of  youngstock may be used to detect calves and 
heifers positive to M. bovis antibodies (Petersen et al., 2016; Petersen et 
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al., 2019). Additionally, PCR analysis from bronchoalveolar lavage fluid 
may be used to identify Mycoplasma species from BRD cases (Cornelissen 
et al., 2017).
2.1.6. Prevalence of  Mycoplasma bovis
2.1.6.1. Prevalence of  Mycoplasma bovis in milk
The exposure to M. bovis-associated diseases is studied by identifying 
M. bovis antibodies from serum and milk both at individual animal and 
herd level. Identification of  herd prevalence of  M. bovis is usually made 
by bulk tank surveys (Fox, 2012). Prevalence of  M. bovis in bulk tank 
milk surveys has fluctuated between zero and 62.4% (Table 1). Bulk 
milk analysis of  M. bovis antibodies revealed that among all Danish dairy 
herds (n = 3,700), 1.5 to 5.2% were antibody-positive for M. bovis in 
bulk tank milk during a one-year study period between June 2013 and 
July 2014 in four consecutive samplings (Arede et al., 2016). Nielsen et al. 
(2015) identified a 7.2% prevalence of  M. bovis antibodies in bulk tank 
milk of  3,437 Danish dairy herds. In Belgium, 17% of  the randomly 
selected hundred bulk milks tested were antibody-positive for M. bovis 
(Gille et al., 2018b). 
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5 The infection rate of  1.3 herds per thousand
Mycoplasma was identified from bovine mastitis cases already in 1960s 
(Jain et al., 1969). During recent years, the prevalence of  Mycoplasma 
mastitis has increased (Fox et al., 2005). A higher prevalence of  
Mycoplasma mastitis is associated with larger herd size (USDA-APHIS, 
2008). In a study from the US, the prevalence of  Mycoplasma in bulk 
tank among herds with more than 500 dairy cows was 14.4% compared 
to prevalence of  1.8% among herds with fewer than 100 dairy cows 
(USDA-APHIS, 2008).
M. bovis has also been identified from clinical mastitis cases even though 
the prevalence varies largely between studies. In one Italian herd, 32 (n 
of  tested cows = 122), cows had clinical signs due to M. bovis mastitis 
evaluated by milk samples of  pooled quarters (Radaelli et al., 2011). In 
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a study by Filioussis et al. (2007), 219 udder quarter milk samples were 
collected from cows with clinical mastitis, with 18 (8.2%) udder quarter 
milk samples being positive for M. bovis. Arcangioli et al. (2011) estimated 
a prevalence of  <0.44% with 95% confidence interval (CI) in clinical 
mastitis cases based on 828 samples of  mastitic milk. 
The within-herd prevalence of  Mycoplasma bovis intramammary infection 
has not been widely studied. Murai et al. (2014) identified a 2.8% (95% 
CI 1.9; 3.7) (n = 1210) within-herd prevalence of  Mycoplasma IMI based 
on cow CMS PCR analyses. Filioussis et al. (2007) analysed cow CMS 
from 111 clinically healthy cows without identifying M. bovis from any 
of  the samples. 
2.1.6.2. Seroprevalence and prevalence of  respiratory 
manifestation of  Mycoplasma bovis
The seroprevalence of  M. bovis antibodies in individual animals varies 
widely depending on the study region and is described to be 82.91% 
(n = 860) in a Hungarian study including 86 cattle farms (Fodor et al., 
2017) and 76.7% (n = 3,670) in a Polish study with 361 herds (Bednarek 
et al., 2012). Hanzlicek et al. (2011) observed M. bovis antibodies in a 
longitudinal study in the US during a 42-day study period, identifying M. 
bovis seroprevalence of  26.6% at day 0 and 98.2% at day 42 in stocker 
calves, respectively. On the contrary, Gulliksen et al. (2009) identified a 
0% seroprevalence for M. bovis during a one-year study in 1,348 calves 
from 135 dairy herds in Norway. Similarly, in a Finnish study by Härtel 
et al. (2004), antibodies against M. bovis were not identified in calves with 
respiratory disease, even though antibodies for another Mycoplasma spp. 
were detected. Ayling et al. (2004) described a seroprevalence of  22% (n 
= 8,959) of  M. bovis antibodies mainly in pneumonic cattle in Britain.
M. bovis-associated respiratory disease is one of  the most common 
manifestations of  mycoplasmosis, especially in calves. Francoz et al. 
(2015) evaluated the prevalence of  M. bovis in 11 dairy herds with high 
incidence of  BRD and detected M. bovis in 19 calves (n = 95) with 
PCR or culture form nasal swab and nasopharyngeal swab samples. 
Additionally, Moore et al. (2015) identified a M. bovis prevalence of  4.8% 
(n = 1,484) in clinically healthy cattle nasal swab samples with PCR. At 
post-mortem examination, Bell and co-workers (2014) identified M. bovis 
from 53 cattle (35.3%) with PCR and from 29 cattle (19.3%) by culture. 
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Castillo-Alcala et al. (2012) studied the prevalence of  M. bovis at multiple 
times after arrival of  cattle to feedlot. They found that prevalence of  M. 
bovis in cattle bronchoalveolar lavage fluid was 1.7% (n = 60) at arrival, 
72.2% (n = 36) at <15 days after arrival and 85.7% (n = 42) at 55 days 
after arrival. M. bovis alone was also detected by culture from 41.1% (n = 
90) of  calves’ lung lesions at slaughterhouse (Soehnlen et al., 2012). On 
the other hand, Bottinelli et al. (2017) found that 85.7% (n = 49) of  nasal 
swab samples from veal calves were positive for Mycoplasma spp. with 
PCR but none of  the samples were PCR positive for M. bovis.
2.1.7. Treatment of  Mycoplasma bovis infections
M. bovis mastitis has been reported to be non-responded to systemic or 
intramammary antibiotic therapy as early as the 1970s, and treatment of  
cows with M. bovis mastitis is not recommended (Maunsell et al., 2011). 
Dry cow therapy with antibiotics is also not effective against M. bovis 
IMI (Ruegg and Erskine, 2015).
Mycoplasma lack a cell wall, leading to resistance against antibiotics 
affecting cell wall of  bacteria. Hence, β-lactam antimicrobials (Fox, 2012) 
or glycopeptides (Gautier-Bouchardon et al., 2014) are not effective in 
the treatment of  Mycoplasma infections. Additionally, Mycoplasma does 
not synthesise folic acid, causing resistance against sulphonamides 
(Rosenbusch et al., 2005). Antimicrobials interfering with microbial 
proteins, such as tetracyclines or macrolides, and nuclein acid synthesis, 
like fluoroquinolones, are in general more effective against Mycoplasma 
(Francoz et al., 2005). However, resistance against the macrolide group 
antimicrobial erythromycin may occur (Rosenbusch et al., 2005). 
Susceptibility testing of  antimicrobials for Mycoplasma in animals is not 
currently standardised, and no official minimum inhibitory concentrations 
(MIC) for Mycoplasma isolated from animals are available (Maunsell et al., 
2011). Therefore, the interpretation of  Mycoplasma susceptibility testing 
for animals should be interpreted with caution.
MIC of  different antimicrobials for M. bovis isolated from milk were 
higher (> 128 µg/ml) compared to MICs for M. bovis isolated from lung 
tissue, indicating resistance according to the Clinical and Laboratory 
Standards Institute (Soehnlen et al., 2011). In general, M. bovis isolated 
from milk have lower susceptibility to antibiotics, such as spectinomycin, 
compared to M. bovis isolated from BRD cases (Rosenbusch et al., 2005; 
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Soehnlen et al., 2011). Heuvelink et al. (2016) identified relatively high 
MIC values of  M. bovis isolates originating from different body sites for 
commonly recommended antimicrobials against M. bovis infections in 
The Netherlands. Fluoroquinolones inhibited the growth of  M. bovis most 
effectively, followed by tulathromycin and oxytetracycline (Heuvelink et 
al., 2016). However, Lysnyansky and Ayling (2016) reported an increase 
in antimicrobial resistance of  M. bovis against tetracyclines, macrolides, 
lincosamides, aminoglycosides, chloramphenicols, and fluoroquinolones. 
Further efforts are needed to find the best options to prevent and control 
M. bovis infections to reduce the antimicrobial resistance.
2.1.8. Control measures for Mycoplasma bovis
To date, the most recommended practice to control Mycoplasma infection 
in dairy herds is to identify the infected animals and to handle those as 
persistently infected (Gonzalez and Wilson, 2003; Maunsell et al., 2011). 
While treatment is not recommended, infected cattle should be culled 
or grouped separately from others, and milking them last in the order is 
recommended (Pfützner and Sachse, 1996; Gonzalez and Wilson, 2003; 
Punyapornwithaya et al., 2011). As new animals introduced to the herd 
is the main risk factor for introducing Mycoplasma infection to the herd, 
farm biosecurity protocols should be up to date, including screening 
the imported animals and employment of  a proper quarantine period 
(Maunsell et al., 2011). The best way to prevent M. bovis infections in a 
herd is to maintain a closed herd (Maunsell et al., 2011).
As Mycoplasma may be detected from bulk milk, that should be tested 
at least once a month both in naïve dairy herds to monitor the disease-
free situation and in herds controlling an endemic disease (Maunsell 
et al., 2011). Clinical mastitis cases, cows with subclinical mastitis and 
fresh cows should be sampled to identify Mycoplasma IMI (Maunsell et 
al., 2011; Fox, 2012). To inhibit the transmission of  Mycoplasma during 
milking, strict milking hygiene should be maintained (Fox et al., 2005; 
Bradley et al., 2012). Endemic Mycoplasma IMI can be controlled with 
sampling and strict milking hygiene. However, risk of  new Mycoplasma 
IMI outbreaks remains (Fox et al., 2005). Investigation of  the whole herd 
is recommended to identify infected animals and to eliminate M. bovis 
IMI as cows with low SCC may also be infected (Ghadersohi et al., 1999; 
Maunsell et al., 2011; Pinho et al., 2013).
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Despite the aforementioned recommendations, Punyapornwithaya et 
al. (2012) did not identify statistically significant associations between 
milking hygiene, culling the infected animals and elimination of  
Mycoplasma infection from a dairy herd. Mycoplasma IMI was eliminated 
from the dairy herds participating in the study during a three-months 
period regardless of  the culling intensity of  infected animals or 
maintenance of  milking hygiene (Punyapornwithaya et al., 2012). 
Contaminated semen, both from breeding bulls and frozen sperm, may 
predispose the introduction and between-animal transmission of  M. bovis 
infection in herds (Gille et al., 2018b; Haapala et al., 2018). Additionally, 
Gille et al. (2018b) identified an absence of  calving pen being a risk 
factor for M. bovis antibody and PCR-positive BTM, probably due to 
increased contact rates between periparturient cows with asymptotic 
carriers in the herd. Both aforementioned aspects should be considered 
when developing control measures for M. bovis infections in dairy herds. 
Furthermore, bedding material contaminated with Mycoplasma bacteria 
should not be used in cattle of  any age (Maunsell et al., 2011).
To inhibit the transmission of  M. bovis infection from dairy cows to calves, 
pasteurised milk could be fed to calves (Butler et al., 2000). Colostrum 
should not be pooled, and colostrum contaminated with M. bovis should 
be withheld from calves (Maunsell et al., 2011). Additionally, good 
housing conditions and management practices to reduce the exposure 
and maximise host defences decrease the risk of  Mycoplasma infections 
among calves (Maunsell et al., 2011). Low stocking density reduces the 
risk of  transmission of  M. bovis by nose-to-nose contact between calves 
as well as airborne transmission of  the pathogen (Nicholas, 2011). 
Vaccination against M. bovis-associated diseases have been unrewarding 
(Maunsell et al., 2011). Vaccines have protected cattle from experimentally 
induced M. bovis infection (Chima et al., 1981; Boothby et al., 1987), but 
in field trials they have been ineffective (Maunsell et al., 2009; Soehnlen 
et al., 2011).
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3. AIMS OF THE STUDY
The aim of  this thesis was to analyze the epidemiology of  M. bovis 
intramammary infection in dairy herds. To fullfill this objective, the 
specific aims covered in this thesis were as follows:
1. Identify the within-herd prevalence and dynamics of  M. bovis IMI in 
Estonian dairy herds (I, II).
2. Evaluate the prevalence of  M. bovis in cow colostrum and clinical 
mastitis samples (II).
3. Evaluate the associations between M. bovis IMI and cow udder health 
and milk yield and composition (I, III).
4. Compare the genotypes of  M. bovis strains isolated from cows’ 
clinical mastitis milk samples and calves’ respiratory samples (II).
5. Evaluate the elimination of  M. bovis IMI from infected udder 
quarters during the dry period (III).
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4. MATERIALS AND METHODS
4.1. Study design
Three studies were designed to cover the objectives of  the research. In 
the three studies, each herd enrolled were positive for M. bovis based on 
herd level bulk tank milk qPCR analysis during the last year (Studies I 
and III) and during the last six months (Study II) before the beginning 
of  the study.
To evaluate the within-herd prevalence of  M. bovis IMI in Study I, a 
cross-sectional study was designed. The study was performed in one 
Estonian loose-housed dairy herd in November 2014. All lactating dairy 
cows of  the herd were tested.
In Study II, a repeated cross-sectional study design was used to evaluate 
the dynamics of  M. bovis IMI in four dairy herds. The study was 
performed between September 2017 and October 2018, within which a 
six-month study period was set for each participating herd. All lactating 
dairy cow CMSs were collected thrice during regular milk-testings in 
three-month intervals. Additionally, colostrum samples were collected 
from all calving cows, and udder quarter milk samples were obtained 
from clinical mastitis cases over the study period. Calf  respiratory 
samples were collected from calves with clinical signs of  respiratory 
disease. Figure 1 illustrates the sampling scheme.
A two-step cross-sectional study was designed in Study III, for which 
one dairy herd was included. Infectious status of  cow udder quarters 
for M. bovis was evaluated at the dry-off  and at the first milking after 
calving for all dairy cows dried off  and calved between November 2014 
and May 2015.
Herd characteristics are given in Table 2 for Studies I and III as well as 































































































































































































































































































































of  the dry 
period (days)
611 Free stall 2 x 12 milking parlour 9,916
259, 000; 
358, 000 65
1Herd average 305-day milk yield
2Herd average somatic cell count per ml of  bulk milk
Table 3. Key parameters for the four study herds in Study II in year 2018
Herd 1 Herd 2 Herd 3 Herd 4
First detection of  
Mycoplasma bovis in bulk 
tank milk
January 2017 January 2017 November 2014
October 
2017
Ct-value of  first study 
month bulk tank milk 
PCR analysis1
34.8 39.4 30.2 33.8
Dairy cows
Avg. number of  cows 591 1,633 552 1,035















Herd avg. 305-day milk 
yield (kg/cow) 10,502 10,404 9,751 10,095
Herd avg. bulk tank 
SCC2 177,000 158,000 391,000 343,000
Separate grouping 
of  cows with clinical 
mastitis
Yes Yes Yes Yes
Milking order of  
clinical mastitis group Last Last Last Last
Separate grouping of  
cows with high SCC3 No No Yes No
Milking order of  high 
SCC3 group Not relevant Not relevant Penultimate Not relevant
Calves ≤6 months of  age
Avg. number of  calves 158 422 164 260







Time spent in individual 
calf  box after birth 7 days 7 days 7 days 7 days











Herd 1 Herd 2 Herd 3 Herd 4
Feeding after 






Pasteurising colostrum No No No No
1 Cycle-threshold value of  first study month bulk tank milk polymerase chain reaction 
analysis
2 Somatic cell count per ml of  milk in bulk tank
3 Somatic cell count over 200 000 cell per ml of  cow composite milk
4.2. Sample collection and handling (I-III)
4.2.1. Collection of  cow composite milk samples (I-II)
For the evaluation of  the within-herd prevalence of  subclinical M. bovis 
IMI (Study I), 522 cow CMSs were collected during a regular milk-testing 
in November 2014 from one Estonian dairy herd. 
For the evaluation of  the changes in within-herd prevalence of  M. bovis 
IMI (Study II), cow CMS were collected three times during routine milk 
recordings in three-month intervals from the study herds (Figure 1).
All CMSs were preserved with bronopol (Broad Spectrum Microtabs 
II, Advanced Instruments INC., USA) and transported to the milk 
laboratory of  the Estonian Livestock Performance Recording centre 
in Tartu. After analysis of  CMS in Estonian Livestock Performance 
Recording centre, 1.5 mL of  each milk sample was collected and 
transported to the Estonian University of  Life Sciences for storage 
(Study I, II) and for pooling (Study II).
Cow CMSs (Study I) and pooled cow CMSs (Study II) were stored at 
–18 °C for further analysis at the Estonian University of  Life Sciences.
4.2.2. Collection of  colostrum samples (II)
Cow composite colostrum samples (40 mL) were collected once at the first 
milking after calving from all dairy cows calving during the study period 
from all four study herds. The colostrum samples were frozen and sent to 
the Estonian University of  Life Sciences for pooling and further analysis. 
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4.2.3. Collection of  cow clinical mastitis milk samples (II)
Aseptic udder quarter milk samples were collected from all cows 
with clinical mastitis. Clinical mastitis was defined as changes in milk 
appearance alone or together with systemic signs of  illness. 
Before udder quarter milk sample collection, the teat end was cleaned 
with 70% ethanol swabs and allowed to dry. After discarding a few 
streams of  milk, samples (2 to 4 mL) were collected into sterile 10-mL 
plastic tubes. Milk samples were stored at −18 °C and transported to the 
Estonian University of  Life Sciences for further analysis.
4.2.4. Collection of  calf  respiratory samples (II)
Tracheobronchial lavage (TBL), nasal swab samples or deep pharyngeal 
swab samples were collected from five to ten calves once from the study 
herds. Five to ten calves with clinical signs of  respiratory disease were 
chosen for sample collection. Calves having at least one clinical symptom, 
nasal discharge, coughing, high body temperature (≥39.3 °C), difficult 
breathing or dyspnoe in auscultation, scoring a minimum of  1 according 
to the calf  health scoring chart (Buczinski et al., 2015) were chosen for 
sampling. For TBL sampling, calf  nostrils were cleaned with gauze, and 
the sampling tube was placed into the upper respiratory tract. Samples 
were collected with a sterile and flexible sampling catheter (3 mm x 60 
cm). Sampling catheter was first introduced to upper respiratory tract 
through the ventral meatus of  the nose. The catheter was introduced 
further until the caudal pharynx was reached with felt resistance. Further, 
the catheter was introduced to the trachea during the inspiratory phase 
of  the respiratory cycle (McQuirk and Peek, 2019). After introducing 
the catheter to the trachea, 40 mL of  sterile sodium chloride solution 
(0.9%) was inserted into the respiratory tract and immediately aspirated. 
Collected fluid was placed in 10-mL sterile plastic tubes and cooled 
immediately. Calf  nasal swab samples were collected with sterile nasal 
swabs (Sterile Dry Swab, Copan Diagnostics Inc., USA) inserted 5 to 10 
cm into nostrils. For collection of  calves’ deep pharyngeal swab samples, 
calf  nostrils were cleaned with gauze, and samples were collected 
with a sterile nasopharyngeal swab (Dryswab®, United Kingdom) 
inserted approximately 25 cm into the upper respiratory tract. Nasal 
and nasopharyngeal swabs were placed in F-broth for transportation 
and cooled. After collection of  calves’ respiratory samples, these were 
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transported to the Estonian Veterinary and Food Laboratory in Tartu 
for immediate bacterial cultivation.
4.2.5. Pooling of  milk samples (II)
Cow CMSs, colostrum samples and clinical mastitis milk samples were 
pooled due to expected low prevalence of  M. bovis in these samples. At 
the first sample collection, cow CMSs were pooled for five cows’ pools. 
At the second and third sample collection, cow CMSs were pooled for 
20 cows’ pools in Herds III and IV and for 100 cows’ pools in Herds I 
and II. Clinical mastitis udder quarter milk samples were pooled for ten 
quarters’ pools and colostrum samples for ten cows’ and 40 cows’ pools, 
of  which ten cows’ pools were used for M. bovis prevalence estimation. 
For every pool, 2 ml of  individual cow milk sample were used. Pooling 
and the pooled samples’ analysis scheme is illustrated in Figure 2.
All pooled milk samples were stored at –18 °C for further analysis at the 
Estonian University of  Life Sciences.
Figure 2. Pooling and analytical scheme for cow composite milk, colostrum and 
clinical mastitis udder quarter milk samples in Study II. Cow colostrum and clinical 
mastitis milk sample collection was started at the month of  first sampling of  cow 
composite milk samples (CMS) and finished at the last month of  cow CMS collection. 
Cow colostrum samples were pooled for 40 and 10 cows’ pools. First colostrum pools 
of  40 cows were analysed with qPCR, following qPCR analysis of  10 cows’ colostrum 
pools belonging to Mycoplasma (M.) bovis positive pools of  40 cows. Clinical mastitis 
udder quarter milk samples were pooled for pools of  10 udder quarter milk samples
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4.2.6. Collection of  udder quarter milk samples before and after 
dry period (III)
Cow aseptic udder quarter milk samples were collected at dry-off  and 
at the first milking after calving from all cows during November 2014 
and May 2015. Cow udder quarter milk samples were transported and 
stored at the Estonian University of  Life Sciences at −18 °C for further 
analysis.
4.3. Laboratory analytical methods
4.3.1. Analysis of  cow composite milk samples (I)
Milk fat (%), protein (%), urea (mg/L), and SCC (× 1,000/ mL) were 
analysed from CMS with accredited methods using the automatic analyser 
Combifoss 6000 FC (Hilleroed, Denmark) in the milk laboratory of  
Estonian Livestock Performance Recording Centre. A calibrated milk 
meter (Tru-Test Limited, Auckland, New Zealand) was used in the farms 
during the milk-testing to measure the daily milk yield of  each cow. The 
database of  Estonian Livestock Performance Recording Centre was 
used to collect information about cow parity and DIM of  all lactating 
dairy cows.
4.3.2. Quantitative polymerase chain reaction method (I-III)
In all studies, a commercial qPCR test kit Mastitis 4B was used to identify 
the bacterial DNA of  M. bovis (Studies I-III) in addition to the DNA of 
Staph. aureus, Strep. agalactiae and Strep. uberis (Study I and III) directly from 
the CMS, udder quarter milk samples and milk sample pools. Analytical 
scheme for pooled milk samples in study II is shown in Figure 2.
After thawing, the milk samples were vortexed and from each sample, 
500 µL of  milk was used for DNA extraction before PCR analysis 
according to the instructions (http://dna-diagnostic.com/files/
Downloads/Mastit4/Instruction_protocol_M4B_2017.04.26.pdf) 
from the manufacturer (DNA Diagnostic, Risskov, Denmark). The 
PCR mixture consisted of  15 µL of  the qPCR Master Mix and 5 µL of  
purified DNA. The real-time PCR instrument thermal cycler Stratagene 
Mx3005P (Agilent Technologies Inc., Santa Clara, CA) was used for 
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amplification. The amplification conditions were as follows: 95 °C for 1 
min, 1 cycle; 95 °C for 5 s and 60 °C for 25 s, 40 cycles. Cycle threshold 
(Ct) values were reported for all samples. For all bacteria identified in 
the analysis, a Ct value of  ≤37.0 was considered a positive result. The 
assay included controls for the validation of  each run including negative 
DNA extraction controls, internal amplification standard (positive PCR 
controls), and nontemplate control. The assay was validated on both 
bacterial strains and milk samples by DNA Diagnostic. According to 
the internal validation protocol of  the laboratory, the sensitivity and 
specificity of  the test kit Mastitis 4B is 100% when tested directly on a 
bacterial colony.
4.3.3. Microbiolocigal isolation of  Mycoplasma bovis (II)
M. bovis PCR positive pools of  clinical mastitis cases (n = 19) and calves’ 
respiratory samples were cultivated in the Estonian Veterinary and Food 
Laboratory in Tartu. 
Pools of  clinical mastitis milk samples were cultivated using an accredited 
cultivation procedure with a cultivation of  an aliquot of  0.1 ml of  milk 
sample in Mycoplasma-specific Hayflick agar plates (Pfützner and Sachse, 
1996). The aliquot of  milk sample was evenly distributed over the plates 
by sterile spatula and allowed to dry before incubation as described by 
Olde Riekerink et al. (2006). Calves’ respiratory samples were cultivated 
with an isolation method of  Mycoplasma from tissue material. An aliquot 
of  0.01 ml of  calves’ respiratory samples in Friis transport broth were 
evenly inoculated in Friis agar (Yeary and Nietfeld, 2002; Gabinaitiene 
et al., 2011). Incubation in a humid atmosphere at 37 °C under 5% CO2 
concentration for 7 days was performed for both Hayflick agar and Friis 
agar plates. All plates were microscoped daily to detect fried egg-shaped 
Mycoplasma colonies. Suspected colonies were analysed with PCR for M. 
bovis identification (Francoz et al., 2012).
4.3.4. Core genome multilocus sequence typing (II)
For cg-MLST analysis, M. bovis isolates from calves’ respiratory samples 
(n = 5) and clinical mastitis udder quarter milk samples (n = 5) were 
selected from Herds I and III. DNA isolation and WGS was performed at 
Finnish Food Authority as described by Haapala et al. (2018), with minor 
modifications. Nextera® Flex DNA Library Preparation kit (Illumina, 
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USA) was used for library preparation with DNA inputs of  100 ng per 
library and the libraries were sequenced on a MiSeq instrument (Illumina, 
USA) using MiSeq Reagent Kit v2 (500-bp) chemistry (Illumina, USA).
4.3.5. Determination of  milk haptoglobin (III)
The concentration of  Hp in udder quarter milk samples was determined 
using the haemoglobin assay described by Makimura and Suzuki 
(1982), with the modification of  tetramethylbenzidine (0.06 mg/
ml) as chromogen (Alsemgeest et al., 1994) solution. The method has 
been adapted to be used for milk, as described by Kalmus et al. (2013). 
Pooled and lyophilised aliquots of  bovine acute-phase serum were 
used to produce standard curves for assay by serial dilution. Optical 
densities of  the formed complex were measured at 450 nm using a 
spectrophotometer. To calibrate the assay, a bovine sample with a known 
Hp concentration provided by the European Commission Concerted 
Action Project (number QLK5-CT-1999-0153) was used. The working 
range of  the assay was 60 to 1,900 mg/L.
The inter- and intra-assay coefficient of  variation values for Hp analysis 
were <12 and <9%, respectively.
4.4. Statistical analysis (I-III)
A causal diagram was drawn for variables to evaluate their causal 
associations and identify any confounders before statistical analyses in 
Studies I and III. The qPCR test results were dichotomised (positive 
= 1, negative = 0) in all studies for M. bovis and for other bacterium in 
Studies I and III using the qPCR analysis cut-off  value (≤37.0) set by 
the manufacturer.
In Study I, linear regression models were used to analyse the associations 
between presence of  M. bovis in cow CMS and cow milk yield (kg), SCC 
(× 1,000/mL), milk protein percentage, fat percentage, and milk urea 
content (mg/L). Dependent variables in the analysis were cow milk 
yield, SCC, protein and fat percentage and milk urea content. Natural 
logarithm transformation was used for SCC, the square root was taken 
from the milk fat content and an inverse scale was used for milk protein 
content to achieve the normal distribution of  the model residuals. In 
multivariate models, cow parity (categorised into 1, 2 and ≥3 lactations) 
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and DIM (categorised as 1–90, 91–200 and ≥201 DIM) were inserted to 
control for confounding effects. In addition to cow status regarding M. 
bovis as the main predictor, presence of  Staph. aureus and Strep. agalactiae, 
cow parity and DIM were included in the models to control for their 
confounding effect. Due to low number of  qPCR-positive Strep. uberis 
CMS, the cow infection status for that pathogen was not added to the 
risk factor models. Interaction terms were tested for significance to see 
whether the combined effect of  two mastitis pathogens differs from the 
individual effects of  the pathogens tested (Dohoo et al., 2009). Statistical 
significance was assumed at p ≤0.05. Assumptions of  the equal variance 
of  the outcome in all levels of  predictor variables and normal distribution 
of  the residuals were checked graphically (Dohoo et al., 2009).
In study II, the within-herd prevalence of  M. bovis IMI and the prevalence 
of  the pathogen in colostrum and clinical mastitis cases was estimated 
by analysing pooled cow CMS, colostrum and clinical mastitis samples 
with qPCR analysis. Separate calculation was done for within-herd 
prevalence estimation for each herd and sampling round. Pool size varied 
depending on the sampling time as described above. Prevalence of  M. 
bovis in colostrum samples and in clinical mastitis cases was calculated 
separately for each herd within the six-month study period. Ten cows’ 
colostrum samples were used for prevalence estimation in each herd. 
Estimation of  the true within-herd prevalence based on pooled samples 
requires estimations of  test sensitivity (Se) and specificity (Sp) (Boelaert 
et al., 2000). As the objective of  whole herd testing is to identify the 
minimum proportion of  truly infected animals, test Se is considered the 
most important parameter in the calculation of  true prevalence based 
on pooled samples (Murai et al., 2014). In Study II, test Se was set to 
range uniformly between 77 and 81.3% in all pool sizes, as no perfect Se 
estimate was available for pooled milk sample analysis with PCR. Justice-
Allen et al. (2011) described Se of  77% of  bulk tank milk PCR analysis 
for M. bovis. This was applied for the lower test Se of  77% (Justice-Allen 
et al., 2011). Higher limit of  Se 81.3% was adapted from a study by 
Murai et al. (2014) evaluating the within-herd prevalence of  M. bovis IMI 
based on pooled CMS samples in different pool sizes. This range of  test 
Se should not exaggerate the power of  PCR analysis to detect M. bovis 
DNA in low amounts in pooled milk samples. In this study, test Sp was 
not considered to violate the test results because the objective of  a whole 
herd test is not to gauge truly negative results (non-infected animals) 
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(Murai et al., 2014). Hence, no positive PCR results were considered false 
positives in Study II. Test Sp adapted from the manufacturer was set to 
be 99.95% for all pool sizes. 
Calculation of  prevalence estimates was performed in statistical 
programme R (The R Foundation ®) with package prevalence (Centre 
for Burden and Risk Assesment, 2020) and rjags (Sourceforge, 2020) 
using model truePrevPools (R Package Documentation, 2020) for 
estimation of  true prevalence from pooled samples (Boelaert et al., 
2000; Speybroek et al., 2012). The true prevalence from the apparent 
prevalence is estimated with a Bayesian framework with credibility 
intervals (CI) in this model and it considers the relationship between 
individual and pool test characteristics (Boelaert et al., 2000). In Bayesian 
estimation, population parameters are assumed to have an intrinsic 
probability distribution, giving a 95% CI (Gardner, 2002). This indicates 
that the true values have 95% chance of  lying between the limits of  CI 
(Gardner, 2002). As uncertainty on unknown and variable parameters 
in diagnostic test characteristics is considered in the Bayesian model, a 
flexible combination of  complex equations is possible (Speybroek et al., 
2012). Beta posterior distribution, which is the conjugate prior to the 
proportion/probability parameter in a binomial distribution was used 
as prior distribution in this study (Dohoo et al., 2014). Calculation of  
the parameters of  beta distribution was made with function betaExpert 
based on expert information. For this, the best-guess prevalence 
was specified to vary between 0.1% and 20.0% with the most likely 
prevalence of  9.0% specified. The calculated alpha and beta estimates 
of  the beta distribution were used in setting the prior beta distribution 
in the truePrevPools model.
In Study III, the elimination rate of  M. bovis during the dry period was 
calculated. Udder quarters were classified as positive (P) or negative 
(N) for detected M. bovis both at dry off  and postpartum according to 
the results of  udder quarter milk sample qPCR analysis. Principles of  
classification of  elimination and new IMI rates of  M. bovis during the dry 
period were calculated following Dufour and Dohoo (2012) as follows:
Elimination = (Pdry and Npp)/[(Pdry and Npp) + (Pdry and Ppp)], and new 
IMI = (Ndry and Ppp)/[(Ndry and Npp) + (Ndry and Ppp)].
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Ndry and Pdry represent infection status at dry-off, and Npp and Ppp 
represent infection status postpartum. 
In Study III, two models were used separately to investigate the 
associations between milk Hp concentration and M. bovis at dry-off  and 
after calving. Presence of  udder pathogens Staph. aureus, Strep. agalactiae 
and Strep. uberis in udder quarter milk samples at dry-off  and post-partum 
was added to models as confounders. Cow parity was categorised into 
1, 2, 3 and ≥4 lactations and DIM into<300 and ≥301. The presence of  
blood in milk samples was evaluated visually and dichotomised (present 
= 1, absent = 0). To achieve a normal distribution of  the outcome 
variable, the inverse square root (1/square root) transformation for Hp 
concentration was used. According to the causal diagram, the presence 
of  blood in the milk sample, cow parity, DIM and the length of  the 
dry period were possible confounders in both models. A mixed tobit 
regression model was used for estimating the associations between the 
milk Hp concentration and the presence of  udder pathogens in udder 
quarter milk samples at dry-off. The model was chosen due to 17.8% of  
the milk samples being under the detection limit for Hp concentrations 
at dry-off, which would violate the regression model’s assumptions. In 
the tobit regression, all cases above (or below) a specific threshold value 
were censored, although these cases remained in the analysis. Hence, all 
cases of  Hp concentrations under detection limit were censored, although 
these Hp concentrations remained in the analysis. A mixed-effect linear 
regression model was used to estimate the associations between milk Hp 
level and the presence of  tested udder pathogens in udder quarter milk 
samples after calving. The cow was included as a random factor to both 
mixed tobit regression and mixed-effect linear regression models. In 
both models, interaction terms were tested for significance to determine 
whether the combined effect of  two udder pathogens differed from the 
sum of  the individual effects of  the pathogens tested. Assumptions of  
the equal variance of  the outcome in all levels of  predictor variables and 
normal distribution of  the residuals were checked graphically (Dohoo 
et al., 2009). 
Stata IC 10 (StataCorp, College Station, TX) software was used for 
statistical analyses in Studies I and III.
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5. RESULTS
5.1. The prevalence of  Mycoplasma bovis intramammary infection
5.1.1. Within-herd prevalence of  Mycoplasma bovis intramammary 
infection (I and II)
In Study I, 522 cow CMSs were collected. M. bovis alone was detected in 
15.0% (n = 30) of  pathogen-positive milk samples and in combination 
with Strep. agalactiae in 19.5% (n = 39) of  pathogen-positive milk samples. 
In study I, the within-herd prevalence of  M. bovis IMI was 17.2 % 
(n = 90; 95% CI 14.1-20.8) in November 2014. 
In total, 1,533 cow CMSs were collected from Herd I, 4,549 CMSs from 
Herd II, 1,427 CMSs from Herd III and 2,835 CMSs from herd IV 
during the Study II.
The estimated within-herd prevalence of  M. bovis IMI in four study 
herds during the Study II is shown in Table 4. Over four farms, the 
estimated within-herd prevalence of  M. bovis IMI ranged between 0.4% 











































































































































































































































































































































































































































5.1.2. The prevalence of  Mycoplasma bovis in cow colostrum and 
clinical mastitis samples (II)
The prevalence of  M. bovis in cow colostrum samples and in clinical 
mastitis udder quarter milk samples was calculated over four farms. 
During the study, 1,264 colostrum samples were collected from four 
study herds. Ten M. bovis positive colostrum pools (n = 28 tested) of  ten 
cows’ was identified in Herd III. M. bovis was not detected from pools of  
ten cows’ colostrum in Herd I (n = 60 tested), Herd II (n = 23 tested) 
or Herd IV (n = 16 tested). In total, 707 udder quarter milk samples 
were collected from clinical mastitis cases from the four study herds. Six 
M. bovis-positive pools of  clinical mastitis cases originated from Herd I 
(n = 26 tested), one M. bovis-positive pool of  originated from Herd II 
(n = 20 tested), and 13 M. bovis-positive pools of  clinical mastitis cases 
originated from Herd III (n = 23 tested). From Herd IV, seven pools 
of  clinical mastitis cases were available, but none of  these were M. bovis-
positive in PCR analysis.
The estimated prevalence of  M. bovis in cow colostrum in the study 
herds ranged between 1.7% (95% CI 0.2; 2.8) and 4.7% (95% CI 2.7; 
7.1) evaluated by pools of  ten cows’ colostrum samples (Table 5). In 
clinical mastitis cases, the estimated prevalence of  M. bovis in the study 
herds during the study ranged between 3.7% (1.7; 6.4) and 11.0% (7.5; 
15.2) (Table 6). 
Table 5. Prevalence of  Mycoplasma bovis in cow colostrum in study herds during a six-
month study period evaluated by pooled colostrum samples
Herd Mycoplasma bovis posi-tive pools
Total number of  pools 
analysed %
1 95% CI
Herd I 0 23 2.8 0.2; 4.6
Herd II 0 60 1.7 0.2; 2.8
Herd III 4 28 4.7 2.7; 7.1
Herd IV 0 16 3.4 0.3; 5.6
1 Estimated prevalence of  Mycoplasma bovis in colostrum calculated by pools of  ten 
colostrum samples
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Table 6. Prevalence of  Mycoplasma bovis in clinical mastitis cases in study herds during a 
six-month study period evaluated by pooled udder quarter milk samples
Herd Mycoplasma bovis positive pools
Total number of  pools 
analysed %
1 95% CI
Herd I 6 26 5.9 3.7; 8.7
Herd II 1 20 3.7 1.7; 6.4
Herd III 13 23 11.0 7.5; 15.2
Herd IV 0 7 5.0 0.3; 8.5
1 Estimated prevalence of  Mycoplasma bovis in clinical mastitis cases calculated by pools 
of  ten udder quarter milk samples
5.2. Associations between the Mycoplasma bovis IMI and cow 
production indices (I)
A lower (on average –3.0 kg) daily milk yield was associated with the 
presence of  M. bovis in cow CMS compared to cows negative to M. 
bovis. The SCC was significantly higher in cow CMS positive for M. bovis 
compared to cows negative for M. bovis. In the CMS of  cows positive for 
M. bovis, the milk fat and urea content were lower compared to M. bovis-
negative CMS. No significant association was identified between cow 
M. bovis IMI status and milk protein content. The results of  multivariate 
linear regression models evaluating the associations between the udder 
pathogens and cow production indices are presented in Tables 7–11. 
Table 7. Results of  multivariable linear regression model of  association between 
detected mastitis pathogens in cow composite milk samples and daily milk yield (kg) 
of  dairy cows (n=520)
Coefficient 95 % CI p-value Wald test
M. bovis1 neg (n = 430) 
M. bovis pos (n = 90)
0
–3.0 –5.2; –0.8 0.007
Staph. aureus2 neg (n = 467)
Staph. aureus pos (n =53)
0
0.8 –1.8; 3.5 0.546
Strep. agalactiae3 neg (n =372)
Strep. agalactiae pos (n =148)
0
–4.0 –5.9; –2.2 <0.001
1. lactation (n = 220)
2. lactation (n = 159)









<90 DIM (n =133)
91–200 DIM (n = 170)














Table 8. Results of  multivariable linear regression model of  association between 
somatic cell count in cow composite milk samples and mastitis pathogens (n=520)
Coefficient4 95 % CI p-value Wald test
M. bovis1 neg (n = 430) 
M. bovis pos (n = 90)
0
0.8 0.5; 1.1 <0.001
Staph. aureus2 neg (n = 467)
Staph. aureus pos (n =53)
0
0.9 0.5; 1.3 <0.001
Strep. agalactiae3 neg (n =372)
Strep. agalactiae pos (n =148)
0
0.6 0.3; 0.8 <0.001
1. lactation (n = 220)
2. lactation (n = 159)









<90 DIM (n =133)
91–200 DIM (n = 170)












4 estimates are in logarithmic scale
Table 9. Results of  multivariable linear regression model of  association between milk 
fat in cow composite milk samples and mastitis pathogens (n=520)
Coefficient4 95 % CI p-value Wald test
M. bovis1 neg (n = 430) 
M. bovis pos (n = 90)
0
–0.05 –0.1; –0.004 0.035
Staph. aureus2 neg (n = 467)
Staph. aureus pos (n =53)
0
–0.1 –0.07; 0.05 0.732
Strep. agalactiae3 neg (n =372) 0
Strep. agalactiae pos (n =148) 0.05 0.002; 0.09 0.041
1. lactation (n = 220) 0 0.021
2. lactation (n = 159) –0.06 –0.1; –0.01 0.011
≥3. lactation (n = 141) –0.05 –0.1; –0.001 0.046
<90 DIM (n =133) 0 <0.001
91–200 DIM (n = 170) –0.03 –0.08; 0.02 0.233
≥201 DIM (n =217) 0.08 0.04; 0.1 0.001




4 estimates are on a square root scale
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Table 10. Results of  multivariable linear regression model of  association between milk 
protein in cow composite milk samples and mastitis pathogens (n=520)
Coefficient4 95 %CI p-value Wald 
test
M. bovis1 neg (n = 430) 
M. bovis pos (n = 90)
0
0.001 –0.005; 0.007 0.706
Staph. aureus2 neg (n = 467)
Staph. aureus pos (n =53)
0
0.002 –0.006; 0.009 0.674
Strep. agalactiae3 neg (n =372) 0
Strep. agalactiae pos (n =148) –0.006 –0.01; –0.0004 0.034
1. lactation (n = 220) 0 0.282
2. lactation (n = 159) 0.003 –0.002; 0.008 0.214
≥3. lactation (n = 141) 0.004 –0.002; 0.009 0.190
<90 DIM (n =133) 0 <0.001
91–200 DIM (n = 170) –0.02 –0.02; –0.01 <0.001
≥201 DIM (n =217) –0.04 –0.05; –0.04 <0.001




4 estimates are on inverse scale (negative estimate means higher content of  protein)
Table 11. Results of  multivariable linear regression model of  association between milk 
urea (mg/L) in cow composite milk samples and mastitis pathogens (n=520) 
Coefficient 95 % CI p-value Wald test
M. bovis1 neg (n = 430) 
M. bovis pos (n = 90)
0
–15.6 –25.6; –5.6 0.002
Staph. aureus2 neg (n = 467)
Staph. aureus pos (n =53)
0
–6.0 –18.2; 6.3 0.339
Strep. agalactiae3 neg (n =372)
Strep. agalactiae pos (n =148)
0
–7.8 –16.4; 0.7 0.072
1. lactation (n = 220)
2. lactation (n = 159)









<90 DIM (n =133)
91–200 DIM (n = 170)














5.3. Associations between the milk haptoglobin concentration 
and the presence of  Mycoplasma bovis in cow udder quarter milk 
samples (III)
Associations between the presence of  M. bovis in udder quarter milk 
samples at dry off  and post-partum and milk haptoglobin concentration 
were evaluated in Study III. The presence of  M. bovis in udder quarter 
milk sample was not significantly associated with milk Hp concentration 
either at dry-off  or at the first milking after calving. 
5.4. Comparison of  genomes of  Mycoplasma bovis isolates from 
calf  respiratory and cow clinical mastitis samples (II)
In total, 33 respiratory tract samples were collected from calves from four 
study herds. Five M. bovis isolates were identified from the respiratory 
samples. M. bovis isolates were identified from eight udder quarter milk 
sample pools from clinical mastitis cases (Table 12).
Table 12. Mycoplasma bovis isolates from four dairy herds identified by cultivation on 
Hayflick agar at 37 °C and 10% CO2 and used for core genome multilocus sequence 
typing
Herd Number of  samples 
taken




























2 Udder quarter milk sample pool of  10 udder quarters deriving from clinical mastitis 
cases
One calf  respiratory isolate (7163) and cow clinical mastitis (K40) isolate 
originated from Herd I, whereas four calf  respiratory isolates (8769, 
8774, 8758, 8762) and four cow clinical mastitis isolates (K27, K28, 
K16, K24) originated from Herd III (Figure 3) from isolates selected for 
cg-MLST analysis.
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The cg-MLST schema targets covered 58.2% of  the reference genome. 
In total, 527 cg-MLST allele-called targets were extracted and compared 
with each other from the 10 isolates in cg-MLST analysis. M. bovis isolates 
from calves’ respiratory samples and cows’ milk samples clustered 
together within herds. The cow mastitis and calves’ respiratory strains 
had allele differences of  5 in Herd I. In Herd III, mastitis and respiratory 
strains had allele differences 1 to 5, with an exception in sample K27, 
which had an allele difference of  53 compared to other strains from the 
herd. The allele difference between Herd I and Herd III was at least 106 
(Figure 3).
Figure 3. Minimum spanning tree constructed from the core genome multilocus 
sequence typing allele profiles from Mycoplasma bovis strains isolated from cow clinical 
mastitis cases (turquoise circles) and calves’ respiratory samples (red circles) from 
two dairy herds (Herds I and III). Sample ID-numbers are given inside the red and 




















5.5. Elimination of  Mycoplasma bovis during the dry period (III)
In Study III, 1,001 udder quarter milk samples were collected at dry-
off  (n = 510) and after calving (n = 491) from 133 dairy cows. At dry-
off, 191 (37.5%) udder quarter samples out of  510 tested samples were 
positive for one or more of  the detected udder pathogens. M. bovis was 
presented in 2.9% (n = 15) of  the udder quarter milk samples at dry-
off. After calving, 57 (11.6%) of  491 udder quarter milk samples were 
positive for detected udder pathogens. M. bovis was identified in 17 
(3.5%) udder quarter milk samples. 
For M. bovis, the elimination rate during the dry period was 86.7% (n = 
13 M. bovis-negative udder quarter milk samples post-calving, positive at 
dry-off  / n = 15 M. bovis-positive udder quarter milk samples at dry-off) 
and a new IMI rate of  3.0% (n = 15 M. bovis-positive udder quarter milk 
samples post-calving, negative at dry-off  / n = 498 M. bovis negative 
udder quarter milk samples at dry-off). 
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6. DISCUSSION
6.1. The within-herd prevalence of  Mycoplasma bovis 
intramammary infection (I and II)
In a cross-sectional study in November 2014, we identified an M. bovis 
IMI within-herd prevalence of  17.2% in one dairy herd (Study I). In the 
Study II, the within-herd prevalence of  M. bovis IMI varied between four 
dairy herds during a six-month study period. In general, the within-herd 
prevalence of  M. bovis IMI was low, ranging between 0.4% and 12.3%. 
The within-herd prevalence of  M. bovis udder infection has not been 
widely studied in European dairy herds. Most of  the previous studies 
focused on clinical mastitis cases or on herd prevalence of  M. bovis 
(Filioussis et al., 2007; Arcangioli et al., 2011; Radaelli et al., 2011; Passchyn 
et al., 2012). Previously, Brown et al. (1990) identified a 5.7% (n = 1,535) 
within-herd prevalence of  Mycoplasma in one herd. According to the 
study of  Brown et al. (1990) a three times higher within-herd prevalence 
of  M. bovis IMI was found in Study I. 
The study herd of  Study I was also included in Study II (Herd III). The 
within-herd prevalence of  17.2% identified in Study I decreased to 3.2% 
at the lowest in Study II during a three-year period between the two 
studies. Epidemiologic phase of  the infection may affect the within-herd 
prevalence of  IMI. Additionally, the within-herd prevalence of  M. bovis 
IMI may vary with time, and probably, the longer the infection circulates 
in the farm, the lower the within-herd prevalence might be due to better 
immunity of  the cows for M. bovis IMI. Hence, in herds positive to M. 
bovis at all three samplings in Study II, circulation of  the pathogen occurs 
in dairy cows, but assumptions whether this is due to persistent IMI or 
cure and re-occurrence of  IMI cannot be made. The study herds were 
selected based on an M. bovis-positive bulk tank milk sample without 
knowledge about the epidemiologic phase of  the M. bovis IMI. The 
within-herd prevalence was close to zero after the first CMS sampling in 
study Herds I and II, whereas in the herds III and IV, M. bovis-positive 
cow CMS pools were identified during the whole study period. Biddle et 
al. (2003) described an intermittent shedding of  Mycoplasma organism in 
cows with Mycoplasma IMI. Additionally, secreting low concentrations of  
Mycoplasma organisms (106 cells/ml) in CMS is described (Biddle et al., 
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2003). These aspects may affect the within-herd prevalence of  M. bovis 
in the four study herds.
6.2. The prevalence of  Mycoplasma bovis in cow colostrum and 
clinical mastitis samples (II)
The estimated prevalence of  M. bovis in cow colostrum samples was 
low over all four dairy herds in Study II, indicating that in endemically 
infected dairy herds, the shedding of  M. bovis in colostrum is minimal. 
The transmission of  M. bovis infections from dairy cows to calves is 
commonly thought to occur via feeding unpasteurised milk to calves 
(Maunsell and Donovan, 2009). As none of  the study herds pasteurised 
colostrum, the transmission of  M. bovis to calves through colostrum 
could be possible. 
M. bovis may cause both subclinical and clinical mastitis (Bushnell, 
1984; Pothmann et al., 2015; Ruegg and Erskine, 2015). The estimated 
prevalence of  M. bovis in clinical mastitis cases ranged between 3.7% and 
11.0% in the herds during the study. Similar results were described in 
a study by Vähänikkilä et al. (2019), who collected 3,268 udder quarter 
milk samples from clinical and subclinical mastitis cases and identified 
only 51 cows with M. bovis clinical mastitis in recently infected herds 
during a two-year study period. 
6.3. Estimation of  intramammary Mycoplasma bovis within-herd 
prevalence from cow composite and pooled milk samples with 
qPCR (I and II)
Cow CMSs are usually used to detect subclinical mastitis and IMI, 
when it is difficult to identify the infected udder quarter. However, milk 
originating from non-infected udder quarters may lower the sensitivity 
in IMI pathogen detection, due to a dilution effect (Reyher and Dohoo, 
2011). In Study I and II, we used commercial qPCR analysis to detect 
M. bovis from cow CMS. A high sensitivity of  the PCR method to detect 
udder pathogens causing IMI is reported, also when cow CMS are used 
(Friendship et al., 2010; Koskinen et al., 2010; Murai et al., 2014; Nyman 
et al., 2016).
A carry-over of  the udder pathogen DNA may occur when CMSs are 
collected with automated milk metres (Study I and II). Milk from a 
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previously milked cow is mixed with milk from the cow currently being 
milked, leading to false-positive PCR test results (Løvendahl et al., 2010; 
Mahmmod, 2015). In conventional milking systems, the probability 
of  carry-over ranges from 2 to 3.5% (Løvendahl and Bjerring, 2006; 
Løvendahl et al., 2010). The carry-over effect may be associated with 
the Ct-value cut-off  (Mahmmod et al., 2014). Lower cut-off  values in 
discriminating positive and negative test results lower the sensitivity of  
the test but reduce the number of  false-positive test results that may 
occur due to carry over (Mahmmod et al., 2014). Cut-off  value was set 
to be ≤37.0 in Study I, which should be low enough to rule out most 
of  the false-positive results and hence decrease the probability that 
contaminated samples are classified as positive (Mahmmod et al., 2014). 
In Study II, cow CMS samples were pooled, and the dilution effect 
of  pooled CMS decreased the probability of  false-positive qPCR test 
results due to carry-over effect.
We estimated the within-herd prevalence of  M. bovis using pooled 
cow CMSs in Study II. Previous studies have used both pooled udder 
quarter milk samples (Soltau et al., 2017) and CMS (Murai et al., 2014) 
in IMI within-herd prevalence estimation. If  assumed individual-
animal prevalence is <10%, pooled testing is justified (Cowling et al., 
1999). However, comparing to individual animal testing, pooling causes 
a potential decrease in sensitivity (Christensen and Gardner, 2000). 
Additionally, cows do not excrete a steady number of  bacteria with milk 
all the time (Nyman et al., 2016). We used pools of  five, 20 and 100 
cows in within-herd prevalence estimation and 40 and ten cows’ pools 
estimating the prevalence in cow colostrum. Especially in the pools 
of  more than 20 cows, the bacterial DNA might have been below the 
detection limit of  qPCR analysis. However, using pooled cow CMS, 
Murai et al. (2014) identified a Se of  81.3% for M. bovis IMI within-herd 
prevalence estimation strategy with analysing first hundred cows’ CMS 
pools with qPCR following qPCR analysis of  50 cows’ CMS pools and 
then individual cow CMS analysis by culture. In Study II, the Se for the 
calculation of  prevalence estimations was set to a range between 77 and 
81.3%. Additionally, prevalence estimates were calculated based on a 
Bayesian framework, which is an exact method and allows the parameters 
to be unknown (Cowling et al., 1999). With these methods, the prevalence 
estimates were adjusted to imperfect Se when using pooled milk samples 
and the power of  PCR analysis to detect low amounts of  M. bovis DNA 
from large pools is not overestimated.
53
6.4. The associations between cow Mycoplasma bovis 
intramammary infection and milk yield and milk composition (I)
On average, cow daily milk yield was 3.0 kg lower in cows positive for 
M. bovis IMI, evaluated by cow CMS qPCR analysis compared to cows 
negative for M. bovis. Hence, the economic impact of  M. bovis IMI 
on dairy farm production is most probably negative. On the contrary 
Al-Farha et al. (2017) did not find a significant decrease in daily milk 
yield in cows positive for M. bovis. However, Mycoplasma co-infection 
with other udder pathogens resulted in lower daily milk yield. However, 
considering the negative economic impact of  mastitis to dairy producers, 
M. bovis mastitis should also be effectively controlled in dairy operations.
In this study, negative association was found between M. bovis IMI and 
some of  the milk composition parameters. In M. bovis-positive cows the 
milk fat and urea content were lower than in M. bovis-negative cows. 
Changes in milk fat composition and decrease in milk fat content may 
occur due to spontaneous lipolysis during the IMI (Forsbäck et al., 2010). 
Urea is formed in the liver from ammonium and absorbed to the milk from 
the blood in a stable form (Hayton et al., 2012). However, many factors 
influence the milk urea content, such as altered dry matter intake, or the 
lack of  rumen degradable protein and energy in feed ratio (Rezamand 
et al., 2007; Hayton et al., 2012). Therefore, strong conclusions cannot 
be made about the causality of  M. bovis IMI and milk urea content. IMI 
usually causes a decrease in milk protein levels (Rezamand et al., 2007). 
However, we did not find a significant association between the presence 
of  M. bovis in milk samples and milk protein content. Further studies 
using a larger sample size are needed to confirm the associations between 
M. bovis IMI and milk yield as well as milk composition parameters to 
estimate the economic impact of  M. bovis IMI and cow well-being on 
the herd level. 
6.5. Inflammatory response in the Mycoplasma bovis infected 
udder quarters before and after dry period (III)
We did not find a significant association between the milk Hp 
concentration and the presence of  M. bovis in udder quarter milk samples 
at dry off  or at the first milking after calving. To our knowledge, no 
studies have evaluated the presence of  M. bovis in udder quarters and 
local inflammatory response in mammary glands measured via milk Hp 
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concentration. Therefore, further studies should evaluate the factors 
affecting milk Hp concentration in M. bovis-positive udder quarters.
6.6. Comparison of  Mycoplasma bovis strains (II)
We identified that M. bovis strains originating from calves’ respiratory 
tract and cow clinical mastitis cases clustered together within herds. 
However, the allele difference between M. bovis strains from two herds 
was large, indicating circulation of  different strains in the two herds. 
Calves’ respiratory and cows’ clinical mastitis M. bovis strains had low 
allele differences within herds. In Herd III, one exception was a clinical 
mastitis M. bovis strain, which differed from other pathogen strains 
originating form calves’ respiratory samples and clinical mastitis udder 
quarter milk samples. Subclinically infected and imported animals may 
transfer new M. bovis strains to a naïve dairy herd (Fox, 2012). In 2016, 
Herd III created a beef  unit housed close to a dairy youngstock barn and 
direct contact was possible between beef  cattle and dairy heifers over 
the fence on pasture. This may have caused the transmission of  new M. 
bovis strains to the dairy unit.
Herd-specific M. bovis strains and a close relationship between strains 
originating from animals in different ages refers to transmission of  
pathogen between dairy cows and calves. Contaminated milk is commonly 
thought to be a transmitter of  M. bovis between dairy cows during milking 
and between cows and calves (Maunsell and Donovan, 2009; Fox 2012). 
Calves were fed with individual cow colostrum originating from cows 
from the same study herd followed by milk from post-partum cows for 
two to four days after birth and then milk replacer until weaning in all 
the study herds. Additionally, calves were separated from their dams 
immediately after birth, but housed in individual boxes in a calving barn 
during the first week of  life. As M. bovis may survive in cool and humid 
conditions for long periods (Pfützner, 1984) and air-borne transmission 
of  M. bovis is also described (Nicholas, 2011), a transmission of  M. bovis 
between dairy cows and calves is possible during the first week of  calves’ 
lives. After moving to group pens, direct transmission between calves and 
indirect transmission of  M. bovis through farm personnel’s contaminated 
hands and equipment is possible. Further molecular epidemiologic and 
longitudinal studies should evaluate the specific transmission routes of  
M. bovis between adult dairy cows and calves. 
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6.7. Elimination of  Mycoplasma bovis during the dry period (III)
A high elimination rate for M. bovis during the dry period was identified 
in Study III. M. bovis is described to be resistant to many antibiotics, 
including cloxacillin (Rosenbusch et al., 2005). In Study III, all cows were 
treated with cloxacillin-based dry cow antibiotic product (Noroclox DC, 
600 mg, Norbrook Laboratories Limited, Newry, Ireland) at dry-off. 
Usually, M. bovis IMI is considered untreatable with dry cow therapy 
(Ruegg and Erskine, 2015). As dry cow antibiotic therapy should be 
ineffective against M. bovis IMI, the elimination of  M. bovis during 
the dry period is probably caused by other factors. These factors may 
include altered cow immunity or unsuitable conditions for Mycoplasma 
cells in dry mammary glands. However, the sample size in this study was 
small, and therefore the results are only indicative. Future studies should 
evaluate the factors affecting the elimination of  M. bovis during the dry 
period in a larger study population. 
Udder pathogens can be detected from milk with high sensitivity using 
PCR (Koskinen et al., 2010). In Study III, we collected cow udder quarter 
milk samples only once before and after the dry period. Cows do not 
excrete a steady number of  bacteria with milk all the time (Nyman et al., 
2016), and in this study, the amount of  bacterial DNA in negative udder 
quarter milk samples may have been below the qPCR detection limit, 
giving false-negative results. Similarly, qPCR also detects the bacterial 
DNA from nonviable bacteria (Nyman et al., 2016; Parker et al., 2018). 
Therefore, qPCR positive udder quarter milk samples in Study III 
may have been falsely classified as positive due to bacterial DNA from 
bacteria already killed by the cows’ immune system. By using repeated 
udder quarter milk sampling, the probability of  false-negative and false-
positive qPCR test results could have been decreased.
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7. CONCLUSIONS
M. bovis IMI was negatively associated with cow daily milk yield, milk 
composition and udder health. Herds should be tested for the presence 
of  M. bovis infection and effective control measures should be used in 
infected herds to reduce economic losses.
The within-herd prevalence of  M. bovis IMI was 17.2% by testing CMSs 
of  522 lactating dairy cows using qPCR in one dairy herd in November 
2014. The within-herd prevalence of  M. bovis IMI varied in four dairy 
herds during a six-month study period between years 2017–2018. In 
general, the within-herd prevalence of  M. bovis was low. Shedding of  M. 
bovis may depend on the phase of  the epidemic and therefore, repeated 
testing of  animals is recommended to assess the extent of  the infection.
In endemically infected dairy herds, the prevalence of  M. bovis in cow 
colostrum is low, indicating a minimal risk of  transmission of  M. bovis to 
calves via colostrum. Herd-specific M. bovis strains isolated from calves 
and cows indicate a within-herd circulation of  the pathogen between 
different age groups in endemically infected dairy herds. Further studies 
should evaluate the importance of  different within-herd transmission 
routes of  M. bovis infection.
The incidence of  M. bovis-induced clinical mastitis is low in endemically 
infected dairy herds. Most probably, M. bovis is not the major pathogen 
causing clinical mastitis in herds with low pathogen within-herd 
prevalence.
Most of  the udder quarter milk samples positive to M. bovis at dry off  
(86.7%) turned to pathogen-negative during the dry period. Further 
studies should evaluate the elimination of  M. bovis IMI during the dry 
period with larger sample size. No significant association between the 
milk Hp concentration and the presence of  M. bovis in udder quarter 
milk samples at dry off  or at the first milking after calving was identified. 
Associations between M. bovis IMI and local inflammatory response in 
the udder should be studied further.
Further studies should also evaluate the dynamics of  M. bovis IMI during 
a longer period of  time to understand better the infection patterns over 
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time. Additionally, the effect of  udder health programs for controlling 
the within-prevalence of  M. bovis IMI in dairy herds should be studied. 
The importance of  different within-herd transmission routes of  M. bovis 
is also necessary. 
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9. SUMMARY IN ESTONIAN
Mycoplasma bovis’e põhjustatud udaranakkuse epidemioloogia 
piimaveisekarjades
Sissejuhatus
Piimakarjakasvatus on üks tähtsamaid põllumajandusharusid Eestis, 
moodustades 28% Eesti põllumajanduse kogutoodangust aastal 2018 
(Maaeluministeerium, 2019). Hea tervisega lüpsilehmadelt saadud kõrge 
kvaliteediga toorpiim tagab Eesti piimatoodete konkurentsivõime. 
Üheks peamiseks haiguseks, mille tõttu piima kvaliteet halveneb, on 
mastiit (Hertl jt, 2014). Mastiit põhjustab suurt majanduslikku kahju, 
eeskätt suurenenud ravikulu, saamatajäänud piima ja lehmade enneaegse 
karjast praakimise tõttu (Hertl jt, 2014).
Mastiiti võivad põhjustada mitmed erinevad haigustekitajad, millest 
levinumad on Staphylococcus aureus, Streptococcus uberis ning Escherichia coli. 
Samas on mastiiditekitajate hulgas liike, mille tekitatud kahju on viimasel 
kümnendil seoses karjade ja tootmise intensiivistumisega suurenenud 
(Reksen jt, 2007). Mycoplasma (M.) bovis on mikroobiliik, mis võib 
lehmadel põhjustada mastiiti ning vasikatel liigese- ja kopsupõletikku 
(Bennet ja Jasper, 1978; Pfützner ja Schimmel, 1979). 
M. bovis’e põhjustatud nakkustel on negatiivne majanduslik mõju 
piimaveisekasvatusele, sest nakatunud loomade heaolu halveneb. 
Nimetatud bakteri põhjustatud udaranakkuse tõttu väheneb lehmade 
piimatoodang, halveneb piima kvaliteet ja suureneb piima somaatiliste 
rakkude arv (Fox, 2012; Al-Farha jt, 2017). 
Eesti Jõudluskontrolli Keskuse statistika järgi oli Eestis 2018. aastal 
ligikaudu 85 200 lüpsilehma, kellest 81 821 (96%) lehma kuulus 
vabatahtlikku jõudluskontrollisüsteemi. Keskmine 305-päeva 
piimatoodang ühe lehma kohta oli 2018. aastal jõudluskontrollis osalevates 
karjades 9785 kg. Karjad on aasta-aastalt suurenenud, keskmiselt oli 
nimetatud aastal karjas 160 lüpsilehma (Eesti Jõudluskontrolli Keskus, 
2019).
Sõltumata pikaajalistest teadmistest M. bovis’e olemasolu ja ülemaailmse 
levimuse kohta, on selle haigustekitaja põhjustatud udaranakkuse 
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epidemioloogias mitmeid aspekte, mis vajaksid selgitamist. Näiteks ei ole 
uuritud tegureid, mis mõjutavad M. bovis’e udaranakkusest iseeneselikku 
tervistumist. Samuti on vähe uuritud M. bovis’e põhjustatud udaranakkuse 
riskitegureid ja karjasisest levimust, sh levikuteid. Nende asjaolude 
väljaselgitamine tooks uusi teadmisi nakkuse ohjamisel.
Kirjanduse ülevaade 
M. bovis kuulub Mollicutes’e bakterite perekonda. Need on rakukestata 
bakterid, kellele on omane parasiitne eluviis (Razin, 1997; Rosengarten 
jt, 2000). Loomadel on enim levinud liigiks M. bovis, kuid veiste 
haigestumust võivad esile kutsuda ka M. bovigenitalium, M. californicum, 
M. bovirhinis, M. alkalescens ja M. dispar (Nicholas ja Ayling, 2003; Fox, 
2012; Gioia jt, 2016). Veistel põhjustab M. bovis sagedamini udaranakkust 
(González ja Wilson, 2003), kuid esineda võib ka kopsupõletik igas 
vanuses veistel (Maunsell jt, 2011). Harvemini põhjustab bakter veiste 
aborte (Doig, 1981), meningiiti (Stipkovits jt, 1993), keskkõrva põletikku 
(Francoz jt, 2004; Foster jt, 2009), keratokonjunktiviiti (Alberti jt, 2006) 
ja nahaaluseid abstsesse ning liigesepõletikke (Kinde jt, 1993).
M. bovis’e peamised patogeensed omadused on peremeesorganismi 
rakkudele kinnitumine ja rakku sisenemine, immuunsüsteemi 
mõjutamine ja võime koloniseeruda kudedesse (Maunsell jt, 2011; Fox, 
2012). Kõik nimetatud omadused võimaldavad sellel bakteril vältida 
peremeesorganismi immuunvastust ja põhjustada kroonilisi infektsioone 
(Buchenau jt, 2010; Fox, 2012). 
M. bovis’e nakkus tuuakse tavaliselt karja subkliiniliselt haigete loomadega 
(Fox jt 2003; Gonzalez ja Wilson, 2003; Filioussis jt, 2007; Fox 2012). 
Kuna M. bovis liigitatakse nakkavaks udarapatogeeniks, võib haigustekitaja 
nakatunud loomadelt tervetele üle kanduda lüpsitoimingute käigus (Ruegg 
ja Erskine, 2015). Nakkuse ülekandumine võib nakatunud loomade 
kehaeritistega saastunud keskkonna või toidu vahendusel toimuda 
ka kaudselt, kusjuures saastunud piim on ka nakkuse ülekandeteeks 
vasikatele (Butler jt, 2000; Fox jt, 2005; Justice-Allen jt, 2010; Maunsell 
jt, 2011).  
M. bovis’e nakkuse olemasolu kinnitamiseks karjas saab jahutipiima 
analüüsida mükoplasmavastaste antikehade (Nielsen jt, 2015; Petersen 
jt, 2016; Parker jt, 2017), bakteri DNA (Pinho jt, 2013; Bauman jt, 2018) 
või elusbakterite suhtes (Olde Riekerink jt, 2006; McDonald jt, 2009). 
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Elusa haigustekitaja tuvastamine jahutipiimas annab kinnitust, et karjas 
on vähemalt üks M. bovis’t piimaga eritav lehm (Biddle jt, 2003). M. bovis’e 
antikehade suhtes positiivne jahutipiim näitab haigustekitaja esinemist 
karjas. Karjasisest haigustekitaja levimust ei saa jahutipiima analüüsil 
täpselt tuvastada ning nakatunud loomad tuleb kas individuaalproove 
või grupiproove uurides kindlaks teha (Fox jt, 2005).  
M. bovis’e karjadevaheline levimus varieerub riikide lõikes. Taanis 
läbiviidud uuringutes leiti, et 7,2% uuritud jahutipiimadest olid M. bovis’e 
antikehade suhtes positiivsed (Nielsen jt, 2015). Arede jt (2016) poolt 
korraldatud aastase kestusega uuringus leiti, et M. bovis’e antikehade 
levimus piimaveisekarjades varieerus 1,5–5,2% vahel. Murai jt (2014) 
tuvastas Ameerika Ühendriikides ühe karja 1210 lehma üldpiimaproove 
(nelja udaraveerandi koondproovid) uurides, et 2,8% loomadest olid 
mükoplasmadega nakatunud.   
M. bovis’e põhjustatud mastiit ei allu antibiootikumiravile (Maunsell 
jt, 2011), mistõttu soovitatakse tekitaja suhtes positiivsed loomad 
liigitada püsivalt nakatunuteks ning nad võimalusel karjast praakida. 
Kui praakimine ei ole kohe võimalik, tuleb nakatunud loomad teistest 
loomadest eraldada ja lüpsta viimasena (Pfützner ja Sachse, 1996; 
Gonzalez ja Wilson, 2003; Punyapornwithaya jt, 2011). Parim viis M. 
bovis’e nakkuse ennetamiseks on bioohutusreeglite järgimine (Maunsell jt, 
2011). Hea lüpsihügieen hoiab ära M. bovis’e udaranakkuse ülekandumise 
lüpsitoimingute käigus (Fox jt, 2005; Bradley jt, 2012). Vasikate hulgas 
aitavad nakkuse ülekandumist ohjata head pidamistingimused, väike 
asustustihedus loomagruppides ning vasikatele joodetava toorpiima 
pastöriseermine (Butler jt, 2000, Nicholas, 2011). Vaktsineerimine ei 
ole selle haiguse tõrjes tulemusi andnud. Eksperimentaaluuringutes 
on võrreldes laudatingimustes tehtud katsetega küll saadud paremaid 
tulemusi, kuid vaktsiinide toimet nakkuse ennetamiseks ei ole tõestatud 
(Chima jt, 1981; Boothby jt, 1987; Maunsell jt, 2009; Soehnlen jt, 2011). 
Uurimistöö eesmärgid 
Käesoleva uurimistöö eesmärg oli analüüsida M. bovis’e põhjustatud 
udaranakkuse epidemioloogiat piimaveisekarjades. Spetsiifilised 
eesmärgid olid:
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1. Selgitada M. bovis’e udaranakkuse karjasisene levimus ja dünaamika 
Eesti piimaveisekarjades (artikkel I ja II);  
2. Selgitada M. bovis’e esinemus veiste ternespiimas ja kliiniliste 
mastiitide korral (artikkel II);
3. Leida seoseid M. bovis’e udaranakkuse, piimatoodangu, piima koostise 
ja lehma udaratervise näitajate vahel (artikkel I ja III)  
4. Iseloomustada veiste kliinilisest mastiidist ja vasikate hingamisteedest 
isoleeritud M. bovis’e genotüüpe (artikkel II);
5. Hinnata M. bovis’e udaranakkusest tervenemist kinnisperioodi 
jooksul (artikkel III).
Materjal ja metoodika
Väitekirja kahes esimeses teadusartiklis uuriti M. bovis’e karjasisest 
levimust ning selle mõju piimatoodangule ja udaratervisele. 
M. bovis’e udaranakkuse karjasisese levimuse hindamiseks (artikkel I) 
koguti 2014. aastal ühest Eesti piimaveisekarjast kõikidelt lehmadelt 
üldpiimaproovid (n = 522). Piimast määrati rasva- ja proteiinisisaldus, 
somaatiliste rakkude arv ning karbamiidisisaldus. Lisaks registreeriti 
andmed lehmade piimatoodangu, vanuse ning laktatsioonipäevade arvu 
kohta. Andmed analüüsiti lineaarse regressioonanalüüsiga, kasutades 
statistakaprogrammi STATA IC 10 (StataCorp, College Station, TX).
M. bovis’e udaranakkuse karjasisese levimuse muutust ajas uuriti 
2017–2018. aastal (artikkel II), mil lehma üldpiimaproovid koguti 
neljast mükoplasma mastiiti põdevast piimaveisekarjast kolm korda 
kolmekuulise intervalliga. Esimesest karjast võeti kokku 1533, teisest 
4549, kolmandast 1427 ja neljandast 2835 üldpiimaproovi. M. bovis’e 
esinemuse hindamiseks ternespiimas võeti kõikidelt katseperioodi 
jooksul poeginud lehmadelt üldpiimaproovid (n = 1264) esimese 
poegimisjärgse lüpsi käigus. Piimaproovid võeti ka katseperioodi jooksul 
kliinilisse mastiiti haigestunud lehmade udaraveeranditest (n = 707). 
Proovide mikrobioloogiliseks analüüsiks segati lehmade üldpiimaproovid 
koondproovideks. Sarnaselt talitati ternespiimaproovide ja kliinilise 
mastiidi korral võetud piimaproovidega. Katsealustest karjadest koguti 
proovid ka vasikate hingamiselunditest, et kindlaks teha karjas leviva 
M. bovis’e genotüübi võimalik ülekandumine lehmade ja vasikate vahel. 
Karjasisese levimuse analüüsiks kasutati statistikaprogrammi R (© The 
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R Foundation), kus Bayesiani statistika meetodeid kasutades arvutati 
levimushinnang. 
Väitekirja kolmandas teadusartiklis hinnati udaraveerandite 
kinnisperioodiaegset tervistumist M. bovis’e udaranakkusest ühes Eesti 
piimaveisekarjas. Katses osales 133 lehma, kellelt võeti kinnijäämisel 
igast udaraveerandist piimaproov mikrobioloogiliseks analüüsiks (n = 
510).  Samadelt lehmadelt koguti piimaproovid (n = 491) ka esimesel 
poegimisjärgsel päeval. Lineaarsete regressioonmudelitega uuriti 
tuvastatud udarapatogeenide ja udaraveerandi piimaproovist määratud 
haptoglobiini sisalduse vahelisi seoseid kinnijätmisel ning pärast 
poegimist. Statistiline andmeanalüüs tehti programmiga STATA IC 10 
(StataCorp, College Station, TX). 
Kõikides uuringutes tuvastati M. bovis’e olemasolu piimas reaalaja 
polümeraasi ahelreaktsiooniga (PCR) (Mastitis 4B, DNA Diagnostic, 
Risskov, Taani). M. bovis’e isoleerimiseks vasikate hingamisteedest ja 
kliinilise mastiidi proovidest kasutati mükoplasmaspetsiifilisi söötmeid 
ning isoleeritud mikroobide olemasolu proovis kinnitati PCR-meetodiga. 
Veiste kliinilise mastiidi piimaproovidest ja vasikate hingamiselunditest 
isoleeritud M. bovis genotüpiseeriti tuumagenoomi multilokaalse järjestuse 
tüpiseerimise kaudu (core genome multolocus sequence typing, cg-MLST).   
Tulemused ja arutelu   
Esimese uuringu tulemusena selgus, et M. bovis’e udaranakkuse 
karjasisene levimus oli 17,2% (95% usaldusväärsus 14,1–20,8), mida 
võib lugeda mõõdukaks levimuseks. Bakteri esinemine piimaproovides 
ei sõltunud lehma laktatsioonist ega laktatsioonipäevade arvust. M. 
bovis’e udaranakkus mõjutas lehma piimatoodangut oluliselt – nakatunud 
lehmade päeva piimatoodang oli keskmiselt 3 kg (p-väärtus 0,007) võrra 
madalam võrreldes loomadega, kellel bakteri DNA-d ei tuvastatud. 
Lehmadel, kes olid nakatunud M. bovis’ega, oli logaritmiliselt teisendatud 
somaatiliste rakkude arv piimas 0,8 ühikut (p-väärtus < 0,001) kõrgem 
võrreldes haigustekitaja suhtes negatiivsete loomadega. Lisaks oli 
nimetatud bakteri suhtes positiivsete lehmade piima rasvasisaldus 
0,05 ühikut (p-väärtus 0,035) ja karbamiidisisaldus 15,6 ühikut (mg/l) 
(p-väärtus 0,002) väiksem võrreldes bakteriga mittenakatunud lehmade 
piimaga. Seevastu M. bovis’e positiivsetel lehmadel piima proteiinisisaldus 
ei erinenud oluliselt mittenakatunud lehmade piima proteiinisisaldusest. 
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Need tulemused näitavad, et varjatud M. bovis’e udaranakkusel on 
märkimisväärne mõju lehma piimatoodangule ja -kvaliteedile.
Teise uuringu tulemusena leiti, et M. bovis’e karjasisene levimus varieerus 
karjade lõikes. Keskmine levimushinnang jäi karjade esimesel testimisel 
0,7–7,4% vahele. Teada on, et M. bovis’e udaranakkuse levimus on 
kõrgem suurtes piimaveisekarjades (USDA-APHIS, 2008). Loomade 
tihe paigutus ja üleasustus on M. bovis’e udaranakkuse riskitegur, mille 
puhul nakkuse levik toimub ka erinevate vanusegruppide vahel (Fox 
jt, 2005; Justice-Allen jt, 2010; Maunsell jt, 2011). M. bovis’e levimus 
lehmade ternespiimas oli kõikides karjades siiski väike, jäädes keskmiselt 
1,7–4,7% vahele. Seetõttu võib oletada, et lehmade ternespiima 
individuaalse jootmise korral on haigustekitaja ülekandumine vasikatele 
ternespiimaga vähetõenäoline. M. bovis’e levimus kliinilise mastiidi korral 
võetud piimaproovides oli karjade lõikes keskmiselt 3,7–11,0%, millest 
võib järeldada, et endeemiliselt nakatunud piimaveisekarjades põhjustab 
M. bovis harva kliinilist mastiiti.    
Vasikate hingamiselunditest, ternespiimaproovidest ja kliinilist mastiiti 
põdevate lehmade piimaproovidest pärit M. bovis’e genotüübid 
olid enamjaolt karjasiseselt sarnased. See viitab haigustekitaja 
vanusegruppidevahelisele ülekandele karja sees, mis võib toimuda otsese 
kontaktina vanusegruppide vahel või erinevate ülekandefaktorite, näiteks 
loomatalitajate vahendusel. Ka nimetatud patogeeniga saastunud piim 
võib olla ülekandeteeks täiskasvanud veiste ja vasikate vahel. 
Kolmanda uuringu käigus leiti, et M. bovis’t ei tuvastatud 86,7% udaraveerandi 
piimaproovidest esimesel lüpsil pärast poegimist, mis lehma kinnijätmisel 
olid selle patogeeni suhtes positiivsed. Selle haigustekitaja põhjustatud 
udaranakkus ei allu kinnisperioodiaegsele antibiootikumiravile (Ruegg 
ja Erskine, 2015). Kuigi udarakude on kinnisperioodi ajal ebasoodne 
keskkond bakterite paljunemiseks, võib nimetatud patogeen tungida 
rakkudesse ja püsida seal nakatamisvõimelisena kogu kinnisperioodi. 
Samuti on M. bovis’e eritumine piimaga vahelduv (Biddle jt, 2003), 
mistõttu ei saa väita, et lehmade udaraveerandid tervistusid M. bovis’e 
nakkusest. Haptoglobiin on akuutse faasi proteiin, mille sisaldus 
piimas suureneb udarakoe kahjustuse tagajärjel. Uurimistulemused 
näitasid, et M. bovis’e udaranakkus ei suurendanud oluliselt piima 
haptoglobiinisisaldust. Varasemaid uuringuid M. bovis’e udaranakkuse ja 
paikse põletikureaktsiooni vahel ei ole tehtud. Seetõttu võiksid järgnevad 
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katsed selgitada seoseid piima haptoglobiini kui lokaalse põletikunäitaja 
ja M. bovis’e udaranakkuse vahel.  
Järeldused 
M. bovis’e udaranakkused mõjutavad negatiivselt lehma piimatoodangut 
ja -kvaliteeti ning nakatunud lehmade udaratervis on selle nakkuse 
korral halvem. Igas karjas oleks seetõttu soovitav selgitada mükoplasma 
olemasolu ja udaranakkuse tuvastamisel tõrjemeetmeid rakendada.  
M. bovis udaranakkuse karjasisene levimus oli 17,2% novembris 
2014 tehtud uuringus, kus analüüsiti ühe karja 522 lakteeriva lehma 
üldpiimaproove qPCR meetodiga. M. bovis’e levimus uuringualustes 
karjades varieerus kuuekuulise katseperioodi jooksul aastatel 2017–
2018, kuid oli uuringuperioodi jooksul üldiselt väike ja kõikuv. M. bovis’e 
eritamine piimaga võib sõltuda nakkuse epideemia faasist, mistõttu on 
soovitav loomade korduv uurimine nakkuse ulatuse hindamiseks.  
Endeemiliselt nakatunud piimaveisekarjades oli M. bovis’e levimus 
ternespiimas väike ja võib oletada, et nakkuse ülekande tõenäosus 
vasikatele ternespiima vahendusel oli tühine. Kuna vasikatelt ja 
ternespiimast isoleeritud M. bovis’e genotüübid olid karjasiseseselt 
sarnased, annab see tunnistust nakkuse karjasisesele vanuserühmade 
vahelisele ringlusele. Edasistes uuringutes oleks vaja selgitada M. bovis’e 
erinevate võimalike ülekandeteede tähtsust. 
M. bovis´e väikese levimusega veisekarjades ei ole nimetatud haigustekitaja 
peamiseks kliinilise mastiidi põhjustajaks, sest M. bovis´e põhjustatud 
kliinilise mastiidi esinemus oli väike. 
Suurem osa (86,7%) kinnijätmisel M. bovis’e suhtes positiivsetest 
udaraveeranditest olid pärast poegimist selle patogeeni suhtes negatiivsed. 
Edasistes uuringutes tuleks täiendavalt uurida, kas ja millisel määral 
tervistuvad M. bovis’e udaranakkusega lehmad kinnisperioodi jooksul. 
Samuti ei leitud olulist seost haigustekitaja esinemise ja udaraveerandi 
piimaproovide haptoglobiini sisalduse vahel enne kinnijätmist või pärast 
poegimist. M. bovis’e udaranakkuse ja udara paikse põletikureaktsiooni 
vahelisi seoseid tuleb veel edasistes katsetes uurida.
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Edaspidised mükoplasmaga seotud uuringud võiksid hinnata M. bovis’e 
udaranakkuse dünaamikat pikema ajaperioodi jooksul, et mõista selle 
levimuse muutumist karjas. Samuti tuleks analüüsida mastiidikontrolli 
programmide mõju nakkuse karjasisesele levimusele. Täiendavaid 
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ABSTRACT
Subclinical mastitis is one of the major health prob-
lems in dairy herds due to decreased milk production 
and reduced milk quality. The aim of this study was 
to examine the within-herd prevalence of subclinical 
intramammary infection caused by Mycoplasma bovis 
and to evaluate associations between M. bovis and cow 
daily milk yield, udder health, and milk composition. 
Individual cow composite milk samples (n = 522) were 
collected from all lactating dairy cows in 1 Estonian 
dairy farm in November 2014. Daily milk yield, days in 
milk, and parity were recorded. Collected milk samples 
were analyzed for somatic cell count, milk protein, fat, 
and urea content. The presence of M. bovis, Staphylococ-
cus aureus, Streptococcus agalactiae, and Streptococcus 
uberis in the milk samples was confirmed by quantita-
tive PCR analysis. The within-herd prevalence of M. 
bovis was 17.2% in the study herd. No association was 
observed between days in milk and parity to the pres-
ence of M. bovis in milk. According to linear regression 
analysis, the daily milk yield from cows positive for 
M. bovis was on average 3.0 kg lower compared with 
cows negative for M. bovis. In addition, the presence of 
M. bovis in milk samples was significantly associated 
with higher somatic cell count and lower fat and urea 
content compared with milk samples negative for M. 
bovis. In conclusion, subclinical M. bovis intramammary 
infection is associated with decreased milk yield and 
lower milk quality.
Key words: Mycoplasma bovis mastitis, dairy cow, 
prevalence, milk yield
INTRODUCTION
Mastitis, which can be caused by different udder 
pathogens, is one of the major concerns in dairy herds 
because it causes economic losses to the industry due 
to lower milk production and reduced milk quality 
(Ruegg, 2012; Hertl et al., 2014). In addition, milk fat 
and protein concentration have been shown to decrease 
due to lipolysis and proteolysis in mastitic milk (Larsen 
et al., 2010; Vidanarachchi et al., 2015; Zhang et al., 
2015).
The biggest effect on dairy herd milk quality and 
production arises from contagious mastitis pathogens 
such as Staphylococcus aureus, as well as Streptococcus 
agalactiae (Reksen et al., 2007; Paradis et al., 2010; Sø-
rensen et al., 2010). Mycoplasma bovis, a bacterium lack-
ing a cell wall from genus Mycoplasma, mainly causes 
IMI (Nicholas and Ayling, 2003; Maunsell et al., 2011). 
Mycoplasma bovis is usually classified as a contagious 
mastitis pathogen (USDA APHIS, 2008; Royster and 
Wagner, 2015). Transmission between animals occurs 
mainly at the milking time (Ruegg, 2012). Mycoplasma 
bovis usually causes subclinical or mild clinical IMI, 
which can progress to chronic mastitis. Severe clinical 
mastitis outbreaks may also develop (Bushnell, 1984; 
Pothmann et al., 2015; Ruegg and Erskine, 2015). My-
coplasma bovis mastitis is not treatable with antibiot-
ics; therefore, the control strategies of M. bovis IMI are 
to keep the herd uninfected, and to segregate and cull 
infected cows (Fox et al., 2005; Royster and Wagner, 
2015; Nicholas et al., 2016).
Traditionally, M. bovis has been identified using 
culture-based methods, but due to low sensitivity and 
a long incubation period, molecular diagnostic methods 
have become preferable during recent years (Dorman et 
al., 1983; Sachse et al., 2010; Gioia et al., 2016). Detec-
tion of M. bovis in bulk tank milk samples (BTMS) 
or cow composite milk samples (CMS) by using quan-
titative PCR (qPCR) allows an identification of ud-
der pathogens, including M. bovis, rapidly, with high 
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sensitivity, and without previous isolation of bacteria 
(Ghadersohi et al., 1997; Ghadersohi et al., 1999; Fox et 
al., 2005). Identification of infected herds is best made 
by analyzing BTMS. Mycoplasma bovis positive result 
indicates that the pathogen is introduced to the herd. 
However, the true within-herd prevalence cannot be 
estimated with only a positive BTMS result. Further 
identification of infected cows should be made by ana-
lyzing CMS (Fox et al., 2005).
Although mycoplasmas were identified in North 
America and Europe decades ago, the prevalence of M. 
bovis mastitis is not widely studied (Fox et al., 2005; 
Fox, 2012). The herd prevalence of M. bovis udder in-
fection ranges between 0.9% in Australia and 1.5% in 
Belgium (Passchyn et al., 2012; Morton et al., 2014). 
According to a longitudinal study made in Israel, the 
number of M. bovis-positive dairy herds has increased 
annually from 2008 to 2014 (Lysnyansky et al., 2016). 
However, the within-herd prevalence of M. bovis mas-
titis is still not widely studied to this day. By knowing 
the within-herd prevalence and course of the disease, 
it could be possible to develop functional control pro-
grams and predict new outbreaks. In a study by Murai 
et al. (2014), a within-herd prevalence of M. bovis mas-
titis was 2.8% (n = 1,210). According to the Estonian 
Animal Recording Centre database, 19.6% of BTMS 
(n = 112), analyzed with the PCR method, were posi-
tive to M. bovis in 2013 (Estonian Animal Recording 
Centre, 2014).
To our knowledge, no studies are available about the 
associations between M. bovis mastitis and cow milk 
yield or milk composition. Research about this, how-
ever, would clarify the importance of M. bovis as an 
udder pathogen and as a cause of production losses.
The first objective of this study was to identify the 
within-herd prevalence of subclinical IMI caused by M. 
bovis by qPCR method. The second aim was to find 
associations between subclinical M. bovis infection, cow 
daily milk yield, SCC, and milk composition.
MATERIALS AND METHODS
Characteristics of the Study Herd
The milk samples were collected from one large, 
loose-housing dairy herd in Estonia in November 2014. 
The study herd included 611 dairy cows, of which 89% 
were Estonian Holstein, and 11% were Estonian Red 
breed cows. Cows were milked twice a day in the 2 
× 12 parallel milking parlors. The average 305-d milk 
yield was 9,916 kg and bulk milk SCC ranged between 
259,000 and 358,000 cells/mL in 2014. Mycoplasma bo-
vis was previously detected in BTMS and cow CMS of 
single cows with clinical mastitis by PCR in 2011.
Collection and Analysis of Composite Milk Samples
The CMS of all 525 lactating dairy cows were col-
lected once during the routine milk recording in No-
vember 2014. The daily milk yield of each cow was 
measured by using a calibrated milk meter (Tru-Test 
Limited, Auckland, New Zealand). Parity and DIM of 
all lactating dairy cows were recorded.
All milk samples were preserved with bronopol and 
transported to the milk laboratory of the Estonian Ani-
mal Recording Centre in Tartu. In the laboratory, milk 
fat (%), protein (%), urea (mg/L), and SCC (× 1,000/ 
mL) were analyzed with accredited methods using the 
automatic analyzer Combifoss 6000 FC (Hillerød, Den-
mark).
After analysis, 1.5 mL of each milk sample was col-
lected and transported to the Estonian University of 
Life Sciences. Cows with visible signs of clinical masti-
tis (n = 3) were excluded from the study, and 2 cows 
without production data were excluded only from the 
regression analysis. All milk samples (n = 522) were 
stored at –18°C for further analysis.
qPCR Analysis of Milk Samples
A commercial qPCR test kit Mastit4B (DNA Di-
agnostic A/S, Risskov, Denmark) was used for qPCR 
analysis to detect bacterial DNA directly from the milk 
samples.
The oligos of the Mastitis 4B are designed to detect 
DNA of Staph. aureus, Strep. agalactiae, Strep. uberis, 
and M. bovis. After thawing, the milk samples were vor-
texed and from each sample, 500 μL of milk was used for 
DNA extraction before PCR analysis according to the 
instructions (http://dna-diagnostic.com/files/Down-
loads/Mastit4/Instruction_protocol_M4B_2017.04.26.
pdf) from the manufacturer (DNA Diagnostic, Risskov, 
Denmark). The PCR mixture consisted of 15 μL of 
the qPCR Master Mix and 5 μL of purified DNA. The 
real-time PCR instrument thermal cycler Stratagene 
Mx3005P (Agilent Technologies Inc., Santa Clara, CA) 
was used for amplification. The amplification condi-
tions were as follows: 95°C for 1 min, 1 cycle; 95°C for 
5 s and 60°C for 25 s, 40 cycles. Cycle threshold (Ct) 
values were reported for all samples. For all bacteria 
identified in the analysis, a Ct value of ≤37.0 was con-
sidered a positive result. The assay included controls 
for the validation of each run including negative DNA 
extraction controls, internal amplification standard 
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(positive PCR controls), and nontemplate control. The 
assay was validated on both bacterial strains and milk 
samples by DNA Diagnostic. According to the internal 
validation protocol of the laboratory, the sensitivity 
and specificity of the test kit Mastitis 4B is 100% when 
tested directly on a bacterial colony.
Statistical Analyses
A causal diagram was drawn for variables to evaluate 
their causal associations and identify any confounders. 
Dependent variables were milk yield (kg), SCC (× 
1,000/mL), milk protein, fat percentages, and milk urea 
content (mg/L). Cow parity and DIM were considered 
to be confounders according to the causal diagram. A 
linear regression model was chosen for estimating the 
associations between udder pathogens and milk yield, 
SCC, and milk compositions. The distribution of de-
pendent variables was checked graphically. To achieve 
normal distribution, natural logarithm transformation 
was used for SCC, the square root was taken from the 
milk fat content, and an inverse scale was used for milk 
protein content.
The PCR test results were dichotomized for each 
bacterium as either presence or absence by using the 
cut-off values (≤37.0) set by the manufacturer. Asso-
ciations between the presence of 3 mastitis pathogens 
(M. bovis, Staph. aureus, and Strep. agalactiae) cow 
parity, and DIM were assessed using the χ2 test. Due 
to low number of qPCR-positive Strep. uberis CMS, the 
cow infection status of that pathogen was not added to 
the risk factor models. Statistical significance was set 
at P ≤ 0.05.
Multivariable models were composed separately for 
each production indices serving as outcome variables. 
In multivariable models, cow parity (categorized into 
1, 2, and ≥3 lactations) and DIM (categorized as 1–90, 
91–200, and ≥201 DIM) were inserted to control for 
confounding effects. Dichotomized results (yes = 1, no 
= 0) of M. bovis, Staph. aureus, and Strep. agalactiae 
were included to assess the association with the out-
come variable. Interaction terms were tested for signifi-
cance to see whether the combined effect of 2 mastitis 
pathogens differs from the sum of the individual effects 
of the pathogens tested (Dohoo et al., 2009). Assump-
tions of the equal variance of the outcome in all levels 
of predictor variables and normal distribution of the 
residuals were checked graphically (Dohoo et al., 2009).
The STATA IC 10 (StataCorp, College Station, TX) 
software was used for statistical analyses.
RESULTS
Descriptive Statistics
Out of 522 cow CMS, 38.3% (n = 200) contained 
DNA from at least one targeted bacterial species. The 
DNA of one detected bacterial species was found in 
61% (n = 122), 2 species in 31% (n = 62), and 3 species 
were detected simultaneously in 8% (n = 16) of patho-
gen-positive milk samples. Mycoplasma bovis alone was 
detected in 15% (n = 30) of pathogen-positive milk 
samples and in combination with Strep. agalactiae in 
19.5% (n = 39) of pathogen-positive milk samples. The 
most prevalent bacterial species was Strep. agalactiae 
alone, presented in 37.5% (n = 75) of pathogen-positive 
milk samples. The different combinations of udder 
pathogens in pathogen-positive cow CMS are present 
in Table 1.
Prevalence of Udder Pathogens
The within-herd prevalence of M. bovis was 17.2% 
(n = 90; 95% CI 14.1–20.8). Streptococcus agalactiae 
had the highest within-herd prevalence of 28.4% (n = 
148; 95% CI 24.5–34.2). The within-herd prevalence of 
Staph. aureus was 10.2% (n = 53; 95% CI 7.7–13.1). 
Streptococcus uberis was found only in 5 CMS with 
prevalence of 1% (95% CI 0.3–2.2).
The presence of M. bovis or Staph. aureus was not 
significantly associated with DIM. The probability of 
detecting Strep. agalactiae in milk samples was higher 
Table 1. Different combinations of detected bacteria in pathogen-positive milk samples
Pathogen Number of positive samples (%)
Streptococcus agalactiae 75 (37.5)
Mycoplasma bovis 30 (15.0)
Staphylococcus aureus 14 (7.0)
Streptococcus uberis 3 (1.5)
Mycoplasma bovis, Streptococcus agalactiae 39 (19.5)
Streptococcus agalactiae, Staphylococcus aureus 17 (8.5)
Mycoplasma bovis, Staphylococcus aureus, Streptococcus agalactiae 15 (7.5)
Mycoplasma bovis, Staphylococcus aureus 6 (3.0)
Streptococcus agalactiae, Staphylococcus aureus, Streptococcus uberis 1 (0.5)
Total 200 (100)
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(P < 0.05) in dairy cows in late lactation stage (>201 
DIM) compared with the first 3 mo of lactation. There 
was a significantly higher risk of detecting Staph. au-
reus in milk samples from older cows (≥3 lactations) 
compared with ≤2 lactation dairy cows (Table 2).
Associations Between Detected Mastitis Pathogens 
and Milk Yield, Somatic Cell Count,  
and Milk Composition
The presence of M. bovis DNA in milk samples was 
associated with a lower (−3.0 kg) daily milk yield com-
pared with dairy cows without M. bovis DNA in the 
milk samples. The daily milk yield was also lower (−4.0 
kg) in dairy cows that tested positive for Strep. aga-
lactiae compared with Strep. agalactiae negative dairy 
cows (Table 3).
The lnSCC was significantly higher in milk samples, 
in which DNA from M. bovis, Staph. aureus, and Strep. 
agalactiae was detected, compared with milk samples 
negative for these pathogens (Table 4).
In the CMS of cows positive for M. bovis, the milk 
fat and urea (P < 0.05) content were lower compared 
with the respective values of cows negative for M. bovis. 
Mycoplasma bovis was not significantly associated with 
milk protein content (Tables 5, 6, and 7). The presence 
of Strep. agalactiae in milk samples had a positive as-
sociation with the milk fat content (P = 0.041) and 
protein content (P = 0.034; Tables 5 and 6).
DISCUSSION
Prevalence of Mycoplasma bovis in Cow  
CMS Using qPCR
The within-herd prevalence of subclinical M. bovis 
udder infection is not widely studied in European dairy 
herds. Most of the previous studies are focusing on 
clinical mastitis cases or on between-herd prevalence of 
M. bovis (Filioussis et al., 2007; Arcangioli et al., 2011; 
Radaelli et al., 2011; Passchyn et al., 2012). We identi-
fied a M. bovis within-herd prevalence of 17.2% in one 
dairy herd. Previously, Brown et al. (1990) identified a 
5.7% (n = 1535) prevalence of mycoplasmas based on a 
study in one herd. According to the study of Brown et 
al. (1990), a higher within-herd prevalence of M. bovis 
Table 2. Distribution of detected mastitis pathogens (alone or in combination) in composite milk samples of 













DIM     
 0–90 133 23 (17.3) 15 (11.3) 25 (18.8)
 91–200 170 35 (20.6) 15 (8.8) 53 (31.2)
 ≥201 217 32 (14.7) 23 (10.6) 70 (32.2)*
Parity     
 1 Lactation 220 29 (13.2) 18 (8.2) 58 (26.4)
 2 Lactations 159 30 (18.9) 13 (8.2) 49 (30.8)
 ≥3 Lactations 141 31 (22.0) 22 (15.6)* 41 (29.1)
*Statistically significant in χ2 test (P < 0.05) by DIM or lactation number.
Table 3. Results of multivariable linear regression model of association between detected mastitis pathogens 
in cow composite milk samples and daily milk yield (kg) of dairy cows (n = 520)
Item
Number  
of cows Coefficient 95% CI P-value Wald test
Mycoplasma bovis negative 430 0  
Mycoplasma bovis positive 90 −3.0 −5.2; −0.8 0.007
Staphylococcus aureus negative 467 0  
Staphylococcus aureus positive 53 0.8 −1.8; 3.5 0.546
Streptococcus agalactiae negative 372 0  
Streptococcus agalactiae positive 148 −4.0 −5.9; −2.2 <0.001
1 Lactation 220 0 <0.001
2 Lactations 159 3.7 1.9; 5.5 <0.001
≥3 Lactations 141 3.3 1.4; 5.3 0.001
<90 DIM 133 0 <0.001
91–200 DIM 170 −4.4 −6.5; −2.3 <0.001
≥201 DIM 217 −13.6 −15.6; −11.6 <0.001
Intercept  36.0 34.2; 37.9 <0.001  
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Table 4. Results of multivariable linear regression model of association between SCC in cow composite milk 
samples and mastitis pathogens (n = 520)
Item
Number  
of cows Coefficient1 95% CI P-value Wald test
Mycoplasma bovis negative 430 0  
Mycoplasma bovis positive 90 0.8 0.5; 1.1 <0.001
Staphylococcus aureus negative 467 0  
Staphylococcus aureus positive 53 0.9 0.5; 1.3 <0.001
Streptococcus agalactiae negative 372 0  
Streptococcus agalactiae positive 148 0.6 0.3; 0.8 <0.001
1 Lactation 220 0 <0.001
2 Lactations 159 0.1 −0.2; 0.4 0.459
≥3 Lactations 141 0.6 0.3; 0.8 <0.001
<90 DIM 133 0 <0.001
91–200 DIM 170 0.1 −0.2; 0.4 0.399
≥201 DIM 217 0.5 0.2; 0.8 <0.001
Intercept  3.7 3.4; 4.0 <0.001  
1Estimates are in logarithmic scale.
Table 5. Results of multivariable linear regression model of association between milk fat in cow composite milk 
samples and mastitis pathogens (n = 520)
Item
Number  
of cows Coefficient1 95% CI P-value Wald test
Mycoplasma bovis negative 430 0  
Mycoplasma bovis positive 90 −0.05 −0.1; −0.004 0.035
Staphylococcus aureus negative 467 0  
Staphylococcus aureus positive 53 −0.1 −0.07; 0.05 0.732
Streptococcus agalactiae negative 372 0    
Streptococcus agalactiae positive 148 0.05 0.002; 0.09 0.041  
1 Lactation 220 0   0.021
2 Lactations 159 −0.06 −0.1; −0.01 0.011  
≥3 Lactations 141 −0.05 −0.1; −0.001 0.046  
<90 DIM 133 0   <0.001
91–200 DIM 170 −0.03 −0.08; 0.02 0.233  
≥201 DIM 217 0.08 0.04; 0.1 0.001  
Intercept  2.0 1.95; 2.04 <0.001  
1Estimates are on a square root scale.
Table 6. Results of multivariable linear regression model of association between milk protein in cow composite 
milk samples and mastitis pathogens (n = 520)
Item
Number  
of cows Coefficient1 95% CI P-value Wald test
Mycoplasma bovis negative 430 0  
M. bovis positive 90 0.001 −0.005; 0.007 0.706
Staphylococcus aureus negative 467 0  
Staph. aureus positive 53 0.002 −0.006; 0.009 0.674
Streptococcus agalactiae negative 372 0    
Strep. agalactiae positive 148 −0.006 −0.01; −0.0004 0.034  
1 Lactation 220 0   0.282
2 Lactations 159 0.003 −0.002; 0.008 0.214  
≥3 Lactations 141 0.004 −0.002; 0.009 0.190  
<90 DIM 133 0   <0.001
91–200 DIM 170 −0.02 −0.02; −0.01 <0.001  
≥201 DIM 217 −0.04 −0.05; −0.04 <0.001  
Intercept  0.3 0.30; 0.31 <0.001  
1Estimates are on an inverse scale (negative estimate means higher content of protein).
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IMI was found in our study. However, we collected milk 
samples only once and from a single dairy herd by using 
a high-sensitivity qPCR method to detect major udder 
pathogens from the CMS (Koskinen et al., 2010; Murai 
et al., 2014; Nyman et al., 2016). Therefore, the results 
of this study describe the within-herd prevalence of M. 
bovis only at the single point in time in one specific 
herd.
Cow CMS are used to detect especially subclinical 
IMI when it is difficult to identify the infected udder 
quarter. However, milk originating from noninfected 
udder quarters may lower the sensitivity in IMI patho-
gen detection, due to a dilution effect (Reyher and 
Dohoo, 2011). In this study, we used commercial qPCR 
analysis to detect 4 mastitis pathogens in cow CMS 
simultaneously. A high sensitivity of the PCR method 
to detect udder pathogens causing IMI is reported, 
also when cow CMS are used (Friendship et al., 2010; 
Koskinen et al., 2010; Murai et al., 2014; Nyman et al., 
2016).
A carry-over of the udder pathogen DNA may oc-
cur when CMS are collected with automated milk me-
ters. Milk from a previously milked cow is mixed with 
milk from the cow currently being milked, leading to 
false-positive PCR test results (Løvendahl et al., 2010; 
Mahmmod, 2015). In conventional milking systems, the 
probability of carry-over is evaluated to range from 2 
to 3.5% (Løvendahl and Bjerring, 2006; Løvendahl et 
al., 2010). The carry-over effect may be associated with 
the Ct-value cut-off (Mahmmod et al., 2014). Lower 
cut-off values in discriminating positive and negative 
test results lower the sensitivity of the test, but reduce 
the number of false-positive test results that may occur 
due to carry-over (Mahmmod et al., 2014). The cut-off 
value was set to be ≤37.0 in our study, which should be 
low enough to rule out most of the false-positive results 
and hence decrease the probability that contaminated 
samples are classified as positive (Mahmmod et al., 
2014).
Associations Between Cow Mycoplasma bovis 
Infection and Milk Yield and Milk Composition
To our knowledge this is the first study evaluating 
associations between subclinical M. bovis IMI, cow milk 
yield, SCC, and composition, when cow CMS are used. 
We identified no significant relation between co-infec-
tion with udder pathogens and cow milk yield, SCC, 
or milk composition. This may be due to relatively low 
numbers of samples with multiple pathogens detected 
and should be controlled in further studies using larger 
number of samples.
The presence of M. bovis bacterial DNA in CMS was 
associated with an average of a 3.0 kg lower daily milk 
yield compared with cows negative for M. bovis. The 
negative effect of Strep. agalactiae or Staph. aureus 
subclinical IMI on milk yield was already discovered 
decades ago (Keefe et al., 1997; Reksen et al., 2007). In 
the present study, a negative association between pres-
ence of bacterium in subclinically infected cow CMS 
and milk yield was detected for Strep. agalactiae but 
not for Staph. aureus. Even though the number of M. 
bovis positive dairy cows was low in our study, a signifi-
cant relation between M. bovis and cow daily milk yield 
was identified. As far as we know, no research has been 
published about the association between subclinical M. 
bovis IMI and milk yield. Therefore, this study provides 
essential knowledge about the economic effect of M. 
bovis on dairy farm production.
A significant association was observed between M. 
bovis and milk SCC level after controlling for the pres-
ence of other mastitis pathogens, parity, and DIM. We 
found that in CMS positive for M. bovis, the lnSCC 
was on average 0.8 units higher compared with milk 
Table 7. Results of multivariable linear regression model of association between milk urea (mg/L) in cow 
composite milk samples and mastitis pathogens (n = 520)
Item
Number  
of cows Coefficient 95% CI P-value Wald test
Mycoplasma bovis negative 430 0  
M. bovis positive 90 −15.6 −25.6; −5.6 0.002
Staphylococcus aureus negative 467 0  
Staph. aureus positive 53 −6.0 −18.2; 6.3 0.339
Streptococcus agalactiae negative 372 0  
Strep. agalactiae positive 148 −7.8 −16.4; 0.7 0.072
1 Lactation 220 0 <0.001
2 Lactations 159 −3.8 −12.2; 4.7 0.379
≥3 Lactations 141 −16.8 −25.7; −7.9 <0.001
<90 DIM 133 0 <0.001
91–200 DIM 170 28.2 18.7; 37.7 <0.001
≥201 DIM 217 17.1 8.1; 26.2 <0.001
Intercept   159.4 150.8; 168.0 <0.001  
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samples negative for this pathogen. It is speculated 
that the SCC of cows positive for M. bovis is higher in 
most of the cows, but not all of them (Ghadersohi et 
al., 1999; Pinho et al., 2013). Even though in our study 
there was an association between M. bovis IMI and cow 
SCC, using only cow SCC status in mastitis control 
programs may lead to an omission of some M. bovis 
positive dairy cows (Ghadersohi et al., 1999; Pinho et 
al., 2013).
In our study, the subclinical M. bovis udder infec-
tion was negatively associated with some of the milk 
composition parameters. The milk fat and urea content 
in M. bovis-positive cows was lower than in M. bovis-
negative cows. Spontaneous lipolysis during the IMI 
leads to lower milk fat content and changes in milk fat 
composition (Forsbäck et al., 2010). Urea is formed in 
the liver from ammonium and absorbed to the milk 
from the blood in a stable form (Hayton et al., 2012). 
However, many factors influence the milk urea content, 
such as altered DMI, or the lack of rumen degradable 
protein and energy in feed ratio (Rezamand et al., 
2007; Hayton et al., 2012). Therefore, it is not possible 
to make strong conclusions about the causality of M. 
bovis subclinical IMI and milk urea content.
Intramammary infection usually causes a decrease 
in milk protein levels (Rezamand et al., 2007). In this 
study, we did not find a significant association between 
the presence of M. bovis in milk samples and milk 
protein content. Further studies using a larger sample 
size are needed to confirm the associations between 
subclinical M. bovis IMI and milk yield as well as milk 
composition parameters, making it possible to estimate 
the economic effect of M. bovis IMI and effects on cow 
well-being.
CONCLUSIONS
This study identified the within-herd prevalence of 
subclinical Mycoplasma bovis IMI of 17.2% by testing 
CMS of 522 lactating dairy cows using qPCR. Dairy 
cows infected with M. bovis had higher SCC, produced 
less milk, and had lower milk fat and urea content com-
pared with M. bovis-negative dairy cows. Further stud-
ies should evaluate the associations between M. bovis 
and milk yield and milk quality in a larger number of 
herds. Our findings underlay the importance to apply 
control measures of M. bovis mastitis to reduce eco-
nomic losses due to lower milk yield and milk quality 
caused by subclinical udder infection of M. bovis.
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A B S T R A C T
We aimed to identify the dynamics of the within-herd prevalence of Mycoplasma (M.) bovis intramammary
infection (IMI) in four dairy herds, estimate prevalence of M. bovis in colostrum and clinical mastitis cases and
compare M. bovis strains from calves’ respiratory and cow clinical mastitis samples. Within a six-month study
period, cow composite milk samples (CMS) were collected three times during routine milk recording, first
milking colostrum samples from all calving cows and udder quarter milk samples from clinical mastitis cases.
Calf respiratory samples were collected from calves with respiratory disease. Pooled milk samples were analysed
for M. bovis with the Mastitis 4B polymerase chain reaction (PCR) test kit (DNA Diagnostic A/S). Prevalence
estimates were calculated with Bayesian framework in R statistical programme. cg-MLST was used for M. bovis
genotyping. In Herd I and II first testing M. bovis IMI within-herd prevalence (95 % credibility interval (CI)) was
4.7 % (2.9; 6.8) and 3.4 % (2.3; 4.6), changing to 1.0 % (0.1; 1.7) and 0.8 % (0.1; 1.4) in Herd I and 0.4 % (0.0;
0.7) in Herd II at the next samplings. In Herd III and IV first testing M. bovis IMI within-herd prevalence was 12.3
% (9.7; 15.2) and 7.8 % (6.2; 9.5), changing to 4.6 % (3.0; 6.4) and 3.2 % (1.9; 4.8) in Herd III and to 2.8 % (1.9;
3.8) and 4.9 % (3.6; 6.4) in Herd IV at the next samplings. The estimated prevalence of M. bovis in colostrum
ranged between 1.7 % (0.2; 2.8) and 4.7 % (2.7; 7.1) and in clinical mastitis cases between 3.7 % (1.7; 6.4) and
11.0 % (7.5; 15.2) in the study herds. M. bovis strains isolated from cows and calves clustered within herds
indicating possible transmission of M. bovis between dairy cows and calves. Prevalence of M. bovis in colostrum
and clinical mastitis cases as well as the within-herd prevalence of M. bovis IMI was low in endemically infected
dairy herds.
1. Introduction
Mastitis is one of the most common diseases in dairy cows, causing
economic losses to the dairy industry due to lower milk yield and re-
duced milk quality (Hertl et al., 2014). Mycoplasma (M.) bovis is an
emerging udder pathogen causing intramammary infection (IMI) in
dairy herds (Nicholas and Ayling, 2003; Maunsell et al., 2011). M. bovis
is usually classified as a contagious mastitis pathogen, and it is trans-
mitted between dairy cows mainly during milking procedures (USDA
APHIS, 2008; Ruegg, 2012; Royster and Wagner, 2015). M. bovis may
cause subclinical or mild clinical mastitis, which can progress to
chronic infection. However, severe clinical mastitis outbreaks may also
occur (Bushnell, 1984; Pothmann et al., 2015; Ruegg and Erskine,
2015). M. bovis frequently colonises the respiratory mucosa and may
cause respiratory disease (Rosengarten et al., 2000; Maunsell and
Donovan, 2009). Otitis media and arthritis caused by M. bovis also
occurs in calves (Maunsell et al., 2011). InM. bovis-positive dairy herds,
transmission of M. bovis infection to calves is thought to occur via un-
pasteurised raw milk from cows shedding M. bovis (Maunsell and
Donovan, 2009). Heat treatment or pasteurisation of cow colostrum and
raw milk have been used to reduce and eliminate possible pathogens,
including M. bovis (Stabel et al., 2004; Godden et al., 2006). However,
to our knowledge, no studies have evaluated the presence or prevalence
of M. bovis in cow colostrum as a possible risk factor for infection
transmission from dairy cows to calves.
Mycoplasmas were identified in North America and Europe decades
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ago (Fox et al., 2005; Fox, 2012), but the within-herd prevalence of M.
bovis IMI has not been widely studied. A within-herd prevalence of M.
bovis IMI of 2.8 % (n=1210, 95 % CI 1.9; 3.7) and 0.6 % (95 %
CI=0.0, 1.4) were detected in two herds in a study conducted by
Murai et al. (2014). Additionally, M. bovis IMI within-herd prevalence
of 17.2 % (n=522, 95 % CI 14.1; 20.8) was identified in one Estonian
dairy herd in November 2014 (Timonen et al., 2017). However, there
has been no published longitudinal or repeated studies evaluating the
within-herd prevalence of M. bovis IMI, which would benefit the un-
derstanding of the disease patterns. Polymerase chain reaction (PCR)
detects DNA of udder pathogens from bulk tank milk samples and cow
composite milk samples (CMS) rapidly, with higher sensitivity com-
pared to bacteriologic cultivation, and without preceding bacteriology
(Ghadersohi et al., 1999; Fox et al., 2005; Koskinen et al., 2010). PCR
should be an adequate analysis for the estimation of M. bovis IMI
within-herd prevalence using pooled cow CMS, as it is a cost-effective
diagnostic tool with adequate sensitivity in large dairy herds (Murai
et al., 2014).
Molecular epidemiologic methods are used nowadays to identify
infection sources, transmission and spread of udder pathogens within
and between dairy farms (Gurjar et al., 2012). Multi-locus sequence
typing (MLST) (Lysnyansky et al., 2016) and core genome MLST (cg-
MLST) (Haapala et al., 2018) are successfully used to identify strains of
M. bovis isolated from cattle with mastitis. Genotyping the M. bovis
isolates enables a comparison between M. bovis strains at herd and
animal level and provides a useful tool to identify different transmission
routes of M. bovis infections.
The objective of this study was to evaluate dynamics of within-herd
prevalence of M. bovis IMI in four Estonian dairy herds by using pooled
cow composite milk samples. The second objective of this study was to
evaluate the prevalence of M. bovis in cow colostrum and clinical
mastitis cases by using pooled samples. Additionally, the study aimed to
compare the genotypes of M. bovis strains isolated from cows’ clinical
mastitis udder quarter milk and calves’ respiratory samples.
2. Materials and methods
2.1. Study design and herd characteristics
This repeated cross-sectional study was performed between
September 2017 and October 2018 in four large Estonian dairy herds.
Herd characteristics are given in Table 1. All the study herds were
previously identified to be positive for M. bovis based on the bulk tank
milk PCR analysis at least six months before the beginning of the study.
Bulk tank milk PCR Ct-values ranged between 30.2 and 39.4 in the
study herds at the first study month.
A six-month study period was set for each study herd. For the
evaluation of the within-herd prevalence of M. bovis IMI, cow CMS was
collected from all lactating cows in all study herds three times at three-
month intervals during routine milk recording. Cow composite colos-
trum samples were collected from all cows calving during the study
period. Additionally, udder quarter-level milk samples were collected
from all cows that suffered clinical mastitis during the study period. To
identify the strains of M. bovis in calves, tracheobronchial lavage (TBL),
nasal swab or deep nasopharyngeal swab samples were collected from
five to ten calves with respiratory disease symptoms in the last study
month of the herd. The sample collection scheme is described Fig. 1.
2.2. Collection of milk samples
Cow CMS were collected into 20ml sterile plastic tubes during
regular milk recording. All CMS were preserved with bronopol and
transported to the Estonian University of Life Sciences. Cow colostrum
samples were collected at the first milking after calving by pre-trained
farm personnel. Colostrum samples (40ml) were frozen at the farms
and transported to the Estonian University of Life Sciences. When
clinical mastitis was diagnosed in cow (changes in milk appearance
and/or swollen and/or painful udder quarter), an aseptically collected
udder quarter milk sample was collected by pre-trained farm personnel.
The teat end was cleaned with 70 % ethanol swabs and allowed to dry.
After discarding a few streams of milk, samples (2–4ml) were collected
into sterile 10-ml plastic tubes. Samples were frozen and transported to
the Estonian University of Life Sciences.
2.3. Pooling of milk samples
Based on the PCR analysis of bulk tank milk in the first study month,
the within-herd prevalence of M. bovis IMI was expected to be low in
the study herds, and cow CMS, colostrum and udder quarter milk
samples were pooled at the Estonian University of Life Sciences. For
each pooling, two millilitres of individual milk sample (CMS, colostrum
or udder quarter milk sample) was used. At the first sampling, five
cows’ CMS were pooled. At the second and third samplings, twenty
cows’ CMS were pooled in herds III and IV and 100 cows’ CMS in Herds
I and II. Pools of 20 and 100 cows’ CMS were used due to expected low
within-herd prevalence of M. bovis IMI based on first study month bulk
tank milk PCR analysis. Colostrum pools were combined from 40 cows’
and 10 cows’ colostrum samples as the prevalence of M. bovis in co-
lostrum was expected to be low. Ten udder quarter milk samples ori-
ginating from clinical mastitis cases were pooled for 1 pool. Udder
quarter milk samples collected from clinical mastitis cases and udder
quarter milk sample pools are referred to as “clinical mastitis cases” and
“pools of clinical mastitis cases”, respectively, in the text from here on.
2.4. Collection of calf respiratory samples
TBL, nasal swab or deep nasopharyngeal swab samples were col-
lected from calves (aged 1–6 months) with clinical signs of respiratory
disease once from all dairy herds. A calf health scoring chart (University
of Wisconsin-Madison, 2020) was used to choose the calves for sam-
pling. Calves having at least 1 present clinical symptom (nasal dis-
charge, coughing, high body temperature (≥39.3 °C), difficult
breathing or dyspnoea in auscultation) with scores of 1 were chosen for
sampling. For TBL sampling, the calf was restrained by an assistant, calf
nostrils were cleaned with gauze and the sample was collected with a
sterile and flexible double sampling catheter. The sampling catheter
was first introduced to the upper respiratory tract through the ventral
meatus of the nose. The catheter was introduced further until the
caudal pharynx was reached with felt resistance. Further, the catheter
was introduced to the trachea during the inspiratory phase of the re-
spiratory cycle. When the double catheter was inside the trachea, the
inner catheter was pushed through the silicone plug of the outer ca-
theter and into the lungs as far as possible (Nikunen et al., 2007). Forty
millilitres of sterile sodium chloride solution (0.9 %) was inserted into
the respiratory tract and immediately aspirated. Collected fluid was
placed in 10-ml plastic tubes and cooled. Calf nasal swab samples were
collected with sterile nasal swabs (Sterile Dry Swab, Copan Diagnostics
Inc., USA), inserted circa 5−10 cm to nostrils. For collection of calves’
deep pharyngeal swab samples, calf nostrils were cleaned with gauze.
Samples were collected with sterile nasopharyngeal swab (Dryswab®,
United Kingdom) inserted approximately 25 cm into the upper re-
spiratory tract. Nasal and nasopharyngeal swabs were placed to Friis
broth for transportation and cooled. After collection of calves’ re-
spiratory samples, they were transported to Estonian Veterinary and
Food Laboratory in Tartu for immediate bacterial cultivation.
2.5. Laboratory analysis
2.5.1. PCR analysis
Frozen CMS, colostrum and clinical mastitis udder quarter milk
sample pools were transported to the DNA Diagnostic laboratory in
Risskov, Denmark for PCR analysis. Mastitis 4B, a commercial
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quantitative PCR test kit (DNA Diagnostic A/S, Denmark) was used for
PCR analysis to detect bacterial DNA of M. bovis directly from the milk
samples. Cow colostrum sample pools were analysed in 2 rounds. First,
pools of 40 cows’ colostrum were analysed with PCR and then pools of
10 cows’ colostrum samples belonging to M. bovis PCR positive pools of
40 cows’ colostrum. Further PCR analysis on the individual animal level
was not performed in any of the milk samples. The oligos of the Mastitis
4B are designed to detect DNA of Staphylococcus aureus, Streptococcus
agalactiae, Streptococcus uberis and M. bovis. After thawing, the milk
samples were vortexed and from each sample, 500 μl of milk was used
for DNA extraction before PCR analysis according to the manufacturer’s
instructions (DNA Diagnostic, Risskov, Denmark). The PCR mixture
consisted of 15 μl of the PCR Master Mix and 5 μl of purified DNA. The
thermal cycler Stratagene Mx3005 P real-time PCR instrument (Agilent
Technologies Inc.,Santa Clara, CA) was used for amplification. The
amplification conditions were as follows: 95 °C for 1min, 1cycle; 95 °C
Table 1
Key parameters of the four study herds in the year 2018.
Herd 1 Herd 2 Herd 3 Herd 4
First detection of Mycoplasma bovis in bulk tank
milk
January 2017 January 2017 November 2014 October 2017
Ct-value of first study month bulk tank milk
PCR analysis1
34.8 39.4 30.2 33.8
Dairy cows
Avg. number of cows 591 1,633 552 1,035
Housing system of cows Free stall Free stall Free stall Free stall
Milking system 2×12 Parallel milking
parlour
Carousel 2× 12 Parallel milking parlour 2× 12 Parallel milking
parlour
Herd avg. 305-day milk yield (kg/cow) 10,502 10,404 9,751 10,095
Herd avg. bulk tank SCC2 177,000 158,000 391,000 343,000
Separate grouping of cows with clinical mastitis Yes Yes Yes Yes
Milking order of clinical mastitis group Last Last Last Last
Separate grouping of cows with high SCC3 No No Yes No
Milking order of high SCC group Not relevant Not relevant Penultimate Not relevant
Calves ≤ 6 months of age
Avg. number of calves 158 422 164 260
Separation from dam Immediately after birth Immediately after birth Immediately after birth Immediately after birth
Time spent in individual calf box after birth 7 days 7 days 7 days 7 days
Duration of colostrum feeding 2-4 days since birth 2-4 days since birth 4 days since birth 2-4 days since birth
Feeding after colostrum period Milk powder Milk powder Milk powder (females) Raw milk
(bull calves)
Milk powder
Pasteurising colostrum No No No No
1 Cycle threshold value (Ct-value) of the polymerase chain reaction analysis of bulk tank milk in the first study month of the herd.
2 Somatic cell count per ml of milk.
3 Cows with somatic cell count< 200 000 cells/ml are grouped separately.
Fig. 1. Sample collection scheme for four dairy herds participating in the study between September 2017 and October 2018. A six-month study period was set for
each herd. Cow composite milk samples were collected three times from all dairy herds. Cow colostrum samples and clinical mastitis udder quarter milk samples were
collected during the whole six-month study period in each herd. Calf respiratory samples were collected once at the last study month of the herd. Detection time of
Mycoplasma bovis PCR-positive clinical mastitis udder quarter pools is represented as # and detection time of Mycoplasma bovis PCR-positive colostrum pools as *.
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for 5 s and 60 °C for 25 s, 40 cycles. Cycle threshold (Ct) values were
reported for all samples. For all bacteria identified in the analysis, a Ct
value of ≤37.0 was considered a positive result. The assay included
controls for the validation of each run, including negative DNA ex-
traction controls, internal amplification standard (positive PCR con-
trols) and non-template control. The assay was validated on both bac-
terial strains and milk samples by the DNA Diagnostic. According to the
internal validation protocol of the laboratory, the sensitivity and spe-
cificity of the Mastitis 4B test kit is 1.0 %, when tested directly on a
bacterial colony.
2.5.2. Isolation of M. bovis
Cultivation of M. bovis PCR positive pools of clinical mastitis cases
(n=19) and calves’ respiratory samples was done in the Estonian
Veterinary and Food Laboratory in Tartu. An accredited cultivation
procedure was performed for clinical mastitis milk samples with a
cultivation of an aliquot of 0.1ml of milk sample in mycoplasma-spe-
cific Hayflick agar plates (Pfützner and Sachse, 1996). The aliquot of
milk sample was evenly distributed over the plates by sterile spatula
and allowed to dry before incubation as described by Olde Riekerink
et al. (2006). An isolation method of mycoplasmas from tissue material
was used for cultivation of calves’ respiratory samples. An aliquot of
0.01ml of calves’ respiratory samples in Friis transport broth were
evenly inoculated in Friis agar (Yeary and Nietfeld, 2002; Gabinaitiene
et al., 2011). Both Hayflick agar and Friis agar plates were incubated in
a humid atmosphere at 37 °C under 5 % CO2 concentration for 7 days.
Daily microscopic observation for fried egg shaped mycoplasma co-
lonies was performed. Suspected colonies were analysed with PCR for
M. bovis identification (Francoz et al., 2012).
2.5.3. Core-genome multilocus sequence typing
For cg-MLST analysis, M. bovis isolates from calves’ respiratory
samples (n= 5) and clinical mastitis cases (n=5) were selected from
Herds I and III. DNA isolation and WGS was performed at Finnish Food
Authority as described by Haapala et al. (2018), with minor modifica-
tions. Nextera® Flex DNA Library Preparation kit (Illumina, USA) was
used for library preparation with DNA inputs of 100 ng per library, and
the libraries were sequenced on a MiSeq instrument (Illumina, USA)
using MiSeq Reagent Kit v2 (500-bp) chemistry (Illumina, USA).
2.6. Statistical analysis
The true within-herd prevalence of M. bovis IMI and the prevalence
of M. bovis in cow colostrum and clinical mastitis cases was estimated
based on PCR-positive cow CMS pools, colostrum pools and clinical
mastitis sample pools. Within-herd prevalence of M. bovis IMI was
calculated separately for each herd and sampling round. Pool size
varied depending on the sampling time as described above. Prevalence
of M. bovis in colostrum samples and in clinical mastitis cases was
calculated separately for each herd within the six-month study period.
Ten cows’ colostrum samples were used for prevalence estimation in
each herd.
Estimation of the true within-herd prevalence of M. bovis IMI and
prevalence in colostrum and clinical mastitis cases based on pooled
milk samples requires factors about test sensitivity (Se) and specificity
(Sp) (Boelaert et al., 2000). Sensitivity is considered the most important
parameter in the calculation of true prevalence based on pooled sam-
ples, because the objective is to identify the minimum proportion of
truly infected animals at herd level (Murai et al., 2014). Test sensitivity
(Se) was set to range uniformly between 77 % and 81.3 % in all pool
sizes as no perfect Se estimate was available for pooled milk sample
analysis with PCR. Lower test Se of 77 % was applied according to the
study by Justice-Allen et al. (2011) describing Se of bulk tank milk PCR
analysis for M. bovis. Higher limit of Se 81.3 % was adapted from Murai
et al. (2014) studying within-herd prevalence of M. bovis IMI based on
pooled CMS samples in different pool sizes. This range of test Se should
not exaggerate the power of PCR analysis to detect M. bovis DNA also in
low amounts in pooled milk samples. In contrast, the objective of a
whole herd test is not to gauge truly negative results (non-infected
animals), and test Sp was not considered to violate the test results
(Murai et al., 2014). Hence, no positive PCR results were considered
false-positives. Test specificity (Sp) adapted from the manufacturer was
set to be 99.95 % for all pool sizes.
Statistical programme R (The R Foundation®) was used for the
calculation of prevalence estimates with package prevalence (Center for
Burden and Risk Assesment, 2020) and rjags (Sourceforge, 2020) using
model truePrevPools (R Package Documentation, 2020) for estimation
of true prevalence from pooled samples (Boelaert et al., 2000;
Speybroeck et al., 2012). This model estimates the true prevalence from
the apparent prevalence in a Bayesian framework with credibility in-
tervals (CI). The relationship between individual and pool test char-
acteristics (Boelaert et al., 2000) is considered in the model. Bayesian
estimation assumes population parameters to have an intrinsic prob-
ability distribution giving 95 % CI indicating 95 % chance of the true
values lying between the limits of CI (Gardner, 2002). Uncertainty on
unknown and variable parameters in diagnostic test characteristics is
considered in the Bayesian model allowing a flexible combination of
complex equations (Speybroeck et al., 2012). Prior distribution in this
study was formed as beta posterior distribution, which is the conjugate
prior to the proportion/probability parameter in a binomial distribution
(Dohoo et al., 2014). Function betaExpert was used to calculate the
parameters of a beta distribution based on expert information. For this,
the best-guess prevalence was specified to vary between 0.1 % and 20.0
% with the most likely prevalence of 9.0 % specified. The calculated
alpha and beta estimates of the beta distribution were used in setting
the prior beta distribution in truePrevPools model.
3. Results
3.1. Descriptive statistics
In total, 1,533 CMS were collected from Herd I, 4,549 CMS from
Herd II, 1,427 CMS from Herd III and 2,835 CMS from Herd IV during
the study. Within the study period, 1,264 colostrum samples were
collected from four study herds. Four pools of ten cows’ colostrum
n=28 tested were positive for M. bovis in Herd III. M. bovis was not
detected from pools of ten cows’ colostrum in Herd I (n=60 tested),
Herd II (n= 23 tested) or Herd IV (n=16 tested). During the study
period, 707 udder quarter milk samples were collected from clinical
mastitis cases from the four study herds. Six M. bovis-positive pools of
clinical mastitis cases originated from Herd I (n= 26 tested), one M.
bovis-positive pool of originated from Herd II (n= 20 tested), and 13M.
bovis-positive pools of clinical mastitis cases originated from Herd III
(n= 23 tested). From Herd IV, seven pools of clinical mastitis cases
were available, but none of these wereM. bovis-positive in PCR analysis.
In total, 33 respiratory tract samples were collected from calves
from four study herds. From the respiratory samples, five M. bovis
isolates were identified. M. bovis isolates were identified from eight
udder quarter milk sample pools from clinical mastitis cases (Table 2).
3.2. The estimated within-herd prevalence and prevalence of M. bovis in
colostrum and clinical mastitis samples
The estimated within-herd prevalence of M. bovis IMI in four study
herds during the study is shown in Table 3. Over four farms, the esti-
mated within-herd prevalence ofM. bovis IMI ranged between 0.4 % (95
% CI 0.0; 0.7) and 12.3 (95 % CI 9.7; 15.2) during the study period.
In cow colostrum samples, the estimated prevalence of M. bovis
ranged between 1.7 % (95 % CI 0.2; 2.8) and 4.7 % (95 % CI 2.7; 7.1)
evaluated by pools of ten cows’ colostrum samples (Table 4). The es-
timated prevalence of M. bovis in clinical mastitis cases in the study
herds during the study ranged between 3.7 % (1.7; 6.4) and 11.0 %
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(7.5; 15.2) (Table 5).
3.3. Comparison of M. bovis strains
One calf respiratory isolate and cow clinical mastitis isolate origi-
nated from Herd I, whereas four calf respiratory isolates and 4 cow
clinical mastitis isolates originated from Herd III (Fig. 2).
The cgMLST schema targets covered 58.2 % of the reference
genome. From the 10 isolates in cg-MLST analysis, 527 cgMLST allele-
called targets were extracted and compared with each other. M. bovis
isolates from calves’ respiratory samples and cows’ milk samples clus-
tered together within herds. The cow mastitis and calves’ respiratory
strains had allele differences of 5 in Herd I. In Herd III, mastitis and
respiratory strains had allele differences of 1–5, with an exception in
sample K27, which had an allele difference of 53 compared to other
strains from the herd. Allele difference between Herd I and Herd III was
at least 106 (Fig. 2).
4. Discussion
4.1. Within-herd prevalence of M. bovis intramammary infection
Within-herd prevalence of M. bovis was identified thrice at single
time points with three-month intervals between milk recordings. The
within-herd prevalence of M. bovis IMI varied between four dairy herds
during a six-month study period but was generally low (0.4%–12.3%).
The study herds were selected based on an M. bovis positive bulk tank
milk sample without prior knowledge about the epidemic phase of the
M. bovis IMI. Still, herds were infected at least six months before col-
lection of first cow CMS and close to the start of the study. Hence, a
relatively low within-herd prevalence could be suspected due to high
BTM Ct-values indicating low amount of the pathogen secreted in milk.
In study Herds I and II, the within-herd prevalence was close to zero
after the first CMS sampling whereas in the herds III and IV, M. bovis-
positive cow CMS pools were identified during the whole study period.
These different patterns might be due to different epidemic phases of
the infection as well as strain differences and infection transmission
possibilities in the farms. Also, an intermittent shedding of mycoplasma
organism in cows with mycoplasma IMI could lead to these differences
as described by Biddle et al. (2003). Additionally, some cows with
mycoplasma IMI secrete a low concentration of mycoplasma organisms
(106 cells/ml) in CMS (Biddle et al., 2003). Hence, the results of this
study should be interpreted with caution. Further studies should eval-
uate the dynamics of M. bovis IMI since the time of infection and during
a longer time-span to understand better the pattern of Mycoplasma bovis
IMI.
4.2. The prevalence of M. bovis in colostrum and clinical mastitis cases
This is the first study identifying the prevalence of M. bovis in cow
colostrum samples in large commercial dairy herds. The estimated
prevalence of M. bovis in cow colostrum was low in all study herds,
indicating that in endemically infected dairy herds, the shedding of M.
bovis in colostrum is minimal. Additionally, the estimated prevalence of
M. bovis in clinical mastitis cases ranged between 3.7 % and 11.0 % in
the herds during the study. M. bovis being an infrequent cause of
mastitis in endemically infected herds of this study is consistent with
Table 2
Mycoplasma bovis isolates from four dairy herds identified by cultivation on
Hayflick agar at 37 °C and 10 % CO2 and used for core genome multilocus
sequence typing.
Herd Number of samples
taken
Sample type Number of isolates
I 2 TBL1 1
6 Clinical mastitis case2 1
II 6 Nasal swab 0
2 Deep nasopharyngeal swab 0
1 Clinical mastitis case2 0
III 8 Nasal swab 4
13 Clinical mastitis case2 4
IV 15 Deep nasopharyngeal swab 0
5 Clinical mastitis case2 0
1 Tracheobronchial lavage.
2 Udder quarter milk sample pool of 10 udder quarters deriving from clinical
mastitis cases.
Table 3
Within-herd prevalence of Mycoplasma bovis intramammary infection in study herds during a six-month study period evaluated by pooled cow composite milk
samples.
Sampling First sampling Second sampling Third sampling
Herd n positive/ n total1 %2 95 % CI n positive / n total1 %2 95 % CI n positive / n total1 %2 95 % CI
Herd I 5 / 96 4.7 2.9; 6.8 0 / 53 1.0 0.1; 1.7 0 / 63 0.8 0.1; 1.4
Herd II 9 / 276 3.4 2.3; 4.6 0 / 153 0.4 0.0; 0.7 0 / 153 0.4 0.0; 0.7
Herd III 28 / 92 12.3 9.7; 15.2 10 / 25 4.6 3.0; 6.4 5 / 23 3.2 1.9; 4.8
Herd IV 31 / 187 7.8 6.2; 9.5 10 / 47 2.8 1.9; 3.8 22 / 47 4.9 3.6; 6.4
Pool size 5 cows 20 / 1003 cows 20 / 1003 cows
1 Number of udder pathogen positive pools / number of pools analysed.
2 Estimated within-herd prevalence of Mycoplasma bovis.
3 Pools of hundred cows.
Table 4
Prevalence of Mycoplasma bovis in cow colostrum in study herds during a six-
month study period evaluated by pooled colostrum samples.
Herd Mycoplasma bovis positive
pools
Total number of pools
analysed
%1 95 % CI
Herd I 0 23 2.8 0.2; 4.6
Herd II 0 60 1.7 0.2; 2.8
Herd III 4 28 4.7 2.7; 7.1
Herd IV 0 16 3.4 0.3; 5.6
1 Estimated prevalence of Mycoplasma bovis in colostrum calculated by pools
of ten colostrum samples.
Table 5
Prevalence of Mycoplasma bovis in clinical mastitis cases in study herds during a
six-month study period evaluated by pooled udder quarter milk samples.
Herd Mycoplasma bovis positive
pools
Total number of pools
analysed
%1 95 % CI
Herd I 6 26 5.9 3.7; 8.7
Herd II 1 20 3.7 1.7; 6.4
Herd III 13 23 11.0 7.5; 15.2
Herd IV 0 7 5.0 0.3; 8.5
1 Estimated prevalence of Mycoplasma bovis in clinical mastitis cases calcu-
lated by pools of ten udder quarter milk samples.
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the findings of Vähänikkilä et al. (2019), who collected 3,268 udder
quarter milk samples from clinical and subclinical mastitis cases and
identified only 51 cows with M. bovis clinical mastitis in recently in-
fected herds during a two-year study period. Even though the pre-
valences were low in CMS, colostrum and clinical mastitis cases, waste
milk is not advisable to feed to calves in order to inhibit the trans-
mission of pathogen between age groups. Ideally, colostrum should be
pasteurised before feeding to calves.
4.3. Prevalence estimation using pooled milk samples
We estimated the prevalence of M. bovis using pooled CMS, colos-
trum and clinical mastitis milk samples. Pooled testing to estimate in-
dividual-animal prevalence is justified if assumed prevalence is< 10 %
(Cowling et al., 1999), even though pooling causes a potential decrease
in sensitivity compared to individual-animal testing (Christensen and
Gardner, 2000). We used pools of five to 100 cows’ milk samples in
prevalence estimations as the M. bovis prevalence in study herds was
expected to be low based on the bulk tank milk PCR analysis. Murai
et al. (2014) calculated a Se of 81.3 % for the estimation of M. bovis IMI
within-herd prevalence by using first pools of 100 cows’ CMS analysed
with PCR followed by PCR analysis of 50 cows’ CMS and finally in-
dividual cow CMS cultivation. In this study, Se for the calculation of
prevalence estimations was lowered to a range between 77 % and 81.3
% to adjust the prevalence estimates to imperfect Se when using pooled
milk samples. Calculation of prevalence estimates was based on a
Bayesian framework, which is an exact method and allows the para-
meters to be unknown (Cowling et al., 1999). Hence, the power of PCR
analysis to detect low amounts of M. bovis DNA from large pools is
considered in this study and is not exaggerated.
4.4. Comparison of M. bovis strains
The allele difference between M. bovis strains from two herds was
large, indicating circulation of different strains in the two herds. In
general, calves’ respiratory and cows’ clinical mastitis M. bovis strains
had low allele differences within herds. An exception was one clinical
mastitis M. bovis strain, which differed from other M. bovis strains ori-
ginating form calves’ respiratory samples and clinical mastitis udder
quarter milk samples in Herd III. New M. bovis strains may enter the
dairy herds with subclinically infected and imported animals (Fox,
2012). The farm created a beef unit housed close to a dairy youngstock
barn in 2016, and direct contact was possible between beef cattle and
dairy heifers over the fence on pasture, possibly causing the transmis-
sion of new M. bovis strains to the dairy unit.
Clustered M. bovis strains originating from animals in different ages
within the same herd refers to circulation of pathogen between calves
and cows. M. bovis is commonly thought to be transmitted between
cows and calves through contaminated milk (Maunsell and Donovan,
2009; Fox, 2012). In this study, calves were fed with individual cow
colostrum originating from cows from the same study herd followed by
milk from post-partum cows for two to four days after birth and then
milk replacer until weaning. During the first week of calves’ life, the
calves were immediately separated from their dams and housed in in-
dividual boxes in the same barn. Environmental or air-borne trans-
mission ofM. bovis is possible asM. bovismay survive in cool and humid
conditions for long periods (Pfützner, 1984) and air-borne transmission
of M. bovis has been described (Nicholas, 2011). Hence, transmission of
Fig. 2. Minimum spanning tree constructed from the core genome multilocus sequence typing allele profiles from Mycoplasma bovis strains isolated from cow clinical
mastitis cases (turquoise circles) and calves’ respiratory samples (red circles) from two dairy herds (Herds I and III). Sample ID-numbers are given inside the red and
turquoise circles. Allele differences between isolates are shown in red (For interpretation of the references to colour in this figure legend, the reader is referred to the
web version of this article).
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M. bovis between cows and calves is possible via air-borne or indirect
contact during the first week of calves’ life. Additionally, direct trans-
mission between calves in group pens after the first week of calves’ life
and indirect transmission of M. bovis through farm-personnel’s con-
taminated hands and equipment is possible. Further studies should
evaluate the specific transmission routes ofM. bovis between adult dairy
cows and calves.
5. Conclusions
The estimated average within-herd prevalence of M. bovis IMI
during a six-month study period varied between four dairy herds ran-
ging between 0.4 % and 12.3 %. The within-herd prevalence of M. bovis
IMI and the prevalence of M. bovis in cow colostrum and in clinical
mastitis cases was low in endemically infected dairy herds. Herd-spe-
cificM. bovis strains isolated from calves and cows indicate a circulation
of the pathogen between cattle of different ages. Further studies should
evaluate the dynamics of M. bovis IMI during a longer period, starting
since the introduction of the disease. Additionally, further molecular
epidemiologic studies should evaluate the transmission routes of M.
bovis within dairy herds.
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We aimed to evaluate the elimination of 4 different 
mastitis pathogens, Streptococcus agalactiae, Myco-
plasma bovis, Staphylococcus aureus, and Streptococcus 
uberis, from infected udder quarters during the dry 
period using quantitative PCR. The second purpose 
of this study was to evaluate the association between 
milk haptoglobin (Hp) concentration and the presence 
of udder pathogens (Strep. agalactiae, Staph. aureus, M. 
bovis, and Strep. uberis) in udder quarter milk samples 
before and after dry period. Aseptic udder quarter milk 
samples (n = 1,001) were collected from 133 dairy cows 
at dry off and at the first milking after calving from 1 
large dairy herd. Bacterial DNA of Strep. agalactiae, 
Staph. aureus, Strep. uberis, and M. bovis in the udder 
quarter milk samples was identified with commercial 
quantitative PCR analysis Mastitis 4B (DNA Diag-
nostic A/S, Risskov, Denmark). Milk Hp concentration 
(mg/L) was measured from udder quarter milk samples. 
The elimination rates during the dry period for M. bo-
vis, Staph. aureus, Strep. agalactiae, and Strep. uberis 
were 86.7, 93.6, 96.2, and 100.0%, respectively. The new 
IMI rate was 3.0% for M. bovis, 2.9% for Staph. aureus, 
2.4% for Strep. agalactiae, and 3.1% for Strep. uberis. 
The milk Hp concentration was significantly higher in 
udder quarter milk samples with blood and in samples 
positive for Strep. agalactiae at dry off and for Staph. 
aureus postcalving. Elevated milk Hp concentration 
was not associated with the presence of M. bovis in the 
udder quarter milk samples. In conclusion, elimination 
of Staph. aureus, Strep. agalactiae, and Strep. uberis 
during the dry period was high; the elimination of M. 
bovis from infected udder quarters was lower, but prob-
ably spontaneous. Additionally, milk Hp concentration 
may be used as a marker for udder inflammation when 
combined with the bacteriological results at dry off and 
postpartum.
Key words: udder pathogens, dry period, elimination, 
haptoglobin
INTRODUCTION
Mastitis is one of the major concerns in dairy herds 
because it causes economic losses to the dairy indus-
try due to lower milk yield and reduced milk quality 
(Hertl et al., 2014). Cow mammary glands are more 
susceptible to the invasion of udder pathogens at dry 
off and around calving. Natural defense mechanisms, 
such as lactoferrin, leukocytes, and keratin plug at the 
teat end, are present in the mammary gland, inhibiting 
the invasion and growth of udder pathogens during the 
dry period. To enhance the elimination of udder patho-
gens from infected udder quarters, dry cow antibiotic 
therapy alone or together with internal teat-sealants 
is used at dry off (Bradley and Green, 2004). Usually, 
treatment against Streptococcus agalactiae is effective 
during the dry period, but recovery from Staphylococ-
cus aureus is more difficult; however, some strain differ-
ences affect the elimination of Staph. aureus in dry cows 
(Dingwell et al., 2006). Dry cow therapy is considered 
ineffective in the elimination of Mycoplasma bovis from 
infected udder quarters (Ruegg and Erskine, 2015). 
Traditionally, the presence of udder pathogens before 
and after calving has been identified with culture-based 
methods, but molecular methods, such as PCR, have 
become more common in detecting udder pathogens 
from milk samples worldwide (Koskinen et al., 2010).
The mammary environment during the dry period 
is not advantageous for udder pathogens, and acute 
clinical mastitis rarely occurs in dry cows (Bradley and 
Green, 2004). However, subclinical IMI during the dry 
period serves as a risk factor for clinical mastitis after 
calving (Bradley and Green, 2004). Mastitis-causing 
bacteria entering the mammary gland via the teat canal 
trigger a local inflammatory response and increase the 
level of acute phase proteins in milk (Pyörälä, 2003). 
Haptoglobin (Hp), one of the acute phase proteins, is 
mainly produced in the liver, but local production of 
Hp in mammary gland occurs as Hp is released from 
the damaged epithelial cells and neutrophils of udder 
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tissues (Hiss et al., 2004). Milk Hp concentration can 
be used as a marker for the detection of udder inflam-
mation (Pyörälä, 2003), as both clinical and subclinical 
IMI induce elevated milk Hp concentrations (Nielsen et 
al., 2004; Kalmus et al., 2013).
The elimination rates of Staph. aureus, Strep. agalac-
tiae, and Strep. uberis during the dry period (Bradley 
et al., 2015) and the associations between these udder 
pathogens and milk Hp concentration (Eckersall et al., 
2006; Pyörälä et al., 2011) have been previously de-
scribed. No published studies have examined the elimi-
nation of M. bovis during the dry period. Additionally, 
associations between M. bovis and local inflammatory 
response in the mammary glands measured through 
milk Hp concentration have not been studied to our 
knowledge. The aim of our study was to evaluate the 
elimination of Strep. agalactiae, Staph. aureus, M. 
bovis, and Strep. uberis from infected udder quarters 
during the dry period using quantitative PCR (qPCR) 
method. The second aim of our study was to evaluate 
the association between milk Hp concentration and the 
presence of udder pathogens (Strep. agalactiae, Staph. 
aureus, M. bovis, and Strep. uberis) in udder quarter 
milk samples at dry off and postcalving.
MATERIALS AND METHODS
Study Design
Cow aseptic udder quarter milk samples were col-
lected once at dry off and from the first milking after 
calving between November 2014 and May 2015 from 1 
Estonian dairy herd. All the cows that were dried off 
and calved during that period were sampled.
All the collected udder quarter milk samples (n = 
1,001) were analyzed with qPCR for the detection of 
bacterial DNA of Staph. aureus, Strep. agalactiae, M. 
bovis, and Strep. uberis. Based on the results of the 
qPCR analysis, the elimination rates and new infection 
rates were calculated. After qPCR analysis, milk Hp 
concentration (mg/L) was measured from all collected 
udder quarter milk samples to evaluate the associations 
between the presence of udder pathogens and milk Hp 
concentration.
Characteristics of the Study Herd
The milk samples were collected from 1 Estonian 
large loose-housed dairy herd from northeastern Esto-
nia. Mycoplasma bovis was previously identified in bulk 
tank milk samples and cow composite milk samples in 
clinical mastitis cases in 2013. The study herd included 
611 dairy cows, of which 89% were Estonian Holstein 
and 11% Estonian Red. Cows were milked twice per 
day in a 2 × 12 parallel milking parlor. The average 
305-d milk yield was 9,916 kg, and the bulk milk SCC 
ranged between 259,000 and 358,000 cells/mL in 2014. 
All cows were treated with cloxacillin-based dry cow 
antibiotic product (Noroclox DC, 600 mg, Norbrook 
Laboratories Limited, Newry, UK) at dry off. The 
length of the dry period ranged between 37 and 94 
d (median 65 d). Cow parity, DIM, and the length of 
the dry period were recorded from the database of Es-
tonian Livestock Performance Recording Ltd. (Tartu, 
Estonia).
Collection of Udder Quarter Milk Samples
Cow udder quarter milk samples were collected at 
dry off and at the first milking postpartum. Before 
collection, the teat end was cleaned with 70% etha-
nol swabs and allowed to dry. After discarding a few 
streams of milk, samples (2 to 4 mL) were collected into 
sterile 10-mL plastic tubes. Milk samples were stored 
at −18°C and transported to the DNA Diagnostic A/S 
laboratory for further analysis.
qPCR Analysis of Udder Quarter Milk Samples
Bacterial DNA from M. bovis, Staph. aureus, Strep. 
agalactiae, and Strep. uberis was detected by com-
mercial quantitative qPCR test kit Mastitis 4B (DNA 
Diagnostic A/S). The oligos of the Mastitis 4B are 
designed to detect DNA of Staph. aureus, Strep. agalac-
tiae, Strep. uberis, and M. bovis. After thawing, the milk 
samples were vortexed and from each sample and 500 
μL of milk was used for DNA extraction before PCR 
analysis according to the manufacturer’s instructions 
(DNA Diagnostic A/S, http: / / dna -diagnostic .com/ 
files/ Downloads/ Mastit4/ Instruction _protocol _M4B 
_2017 .11 .01 .pdf). The PCR mixture consisted of 15 μL 
of the qPCR Master Mix and 5 μL of purified DNA. 
The real-time PCR instrument thermal cycler Strata-
gene Mx3005P (Agilent Technologies Inc., Santa Clara, 
CA) was used for amplification. The amplification con-
ditions were 95°C for 1 min for 1 cycle, and 95°C for 5 
s and 60°C for 25 s for 40 cycles. Cycle threshold (Ct) 
values were reported for all samples. For all bacteria 
identified in the analysis, a Ct value of ≤37.0 was con-
sidered a positive result. The assay included controls 
for the validation of each run, including negative DNA 
extraction controls, internal amplification standard 
(positive PCR controls), and nontemplate control. The 
assay was validated on both bacterial strains and milk 
samples by the DNA Diagnostic.
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Determination of Elimination Rate During 
 the Dry Period
According to the results of PCR analysis, udder 
quarters were classified as positive (P) or negative (N) 
for detected udder pathogens both at dry off and post-
partum. Based on different infectious status combina-
tions, elimination and new IMI rates were classified and 
calculated for each detected udder pathogen separately. 
Principles of classification of elimination and new IMI 
rates of the mastitis pathogen during the dry period 
were calculated following Dufour and Dohoo (2012) as
 Elimination = (Pdry and Npp)/[(Pdry and Npp)   
+ (Pdry and Ppp)], and
 New IMI = (Ndry and Ppp)/[(Ndry and Npp)   
+ (Ndry and Ppp)],
where Ndry and Pdry represent infectious status at dry off 
and Npp and Ppp represent infectious status postpartum. 
If an udder quarter was positive for 1 bacterial species 
at dry off and for another bacterial species postcalving, 
the elimination rate was calculated for the bacterial 
species occurring at dry off and a new IMI rate for the 
bacterial species occurring postcalving.
Analytical Determination of Inflammatory Response 
in the Udder Quarter Milk Samples
Milk Hp concentrations (mg/L) were determined by 
a method based on the ability of Hp to bind to hemo-
globin adapted to be used for milk, as described by 
Kalmus et al. (2013). Optical densities of the formed 
complex were measured at 450 nm using a spectro-
photometer. Lyophilized bovine acute phase serum 
was used as a standard, and calibration was carried 
out according to the European Union concerted action 
on the standardization of animal acute phase proteins 
number QLK5-CT-1999–0153 (Skinner, 2001). The 
working range of the assay was 60 to 1,900 mg/L. The 
inter- and intra-assay coefficient of variation values for 
Hp analysis were <12 and <9%, respectively.
Statistical Analyses
The qPCR test results were dichotomized for each 
bacterium as either presence or absence of udder 
pathogen by using the cutoff values (≤37.0) set by the 
manufacturer. Cow parity was categorized into 1, 2, 
3, and ≥4 lactations and DIM into ≤300 and ≥301. 
According to visual evaluation, the presence of blood 
in milk samples was dichotomized as either presence or 
absence (yes = 1, no = 0).
Two models were used separately for investigating 
associations between milk Hp concentration and udder 
pathogens at dry off and after calving. To achieve a nor-
mal distribution of the outcome variable, inverse square 
root (1/square root of Hp) transformation was used. 
According to the causal diagram, the presence of blood 
in the milk sample, cow parity, DIM, and the length 
of the dry period were possible confounders in these 
models. A mixed tobit regression model (Figure 1) was 
used for estimating the associations between the milk 
Hp concentration and the presence of udder pathogens 
in udder quarter milk samples at dry off, as, at dry off, 
17.8% o milk sample were under the detection limit for 
Hp concentrations, which would violate the regression 
model’s assumptions. In the tobit regression, all cases 
above (or below) a specific threshold value were cen-
sored, although these cases remained in the analysis. 
A mixed linear regression model (Figure 2) was used 
to estimate the associations between milk Hp level and 
the presence of udder pathogens in udder quarter milk 
samples after calving. The cow was included as a ran-
dom factor to both models.
In both models, interaction terms were tested for sig-
nificance to determine whether the combined effect of 2 
udder pathogens differed from the sum of the individual 
effects of the pathogens tested. P-values ≤0.05 were 
considered statistically significant. Assumptions of the 
equal variance of the outcome in all levels of predictor 
variables and normal distribution of the residuals were 
checked graphically. Stata IC 10 (StataCorp, College 
Station, TX) software was used for statistical analyses.
RESULTS
Identification of Mastitis Pathogens
In total, 1,001 udder quarter milk samples were col-
lected at dry off (n = 510) and after calving (n = 491) 
from 133 dairy cows. At dry off, 191 (37.5%) udder 
quarters out of 510 were positive for 1 or more of the 
detected udder pathogens. The most prevalent udder 
pathogen was Strep. agalactiae (n = 132; 25.9%), fol-
lowed by Staph. aureus (n = 63; 12.4%) and M. bovis 
(n = 15; 2.9%).
After calving, 57 (11.6%) of 491 udder quarter milk 
samples were positive for detected udder pathogens. 
Mycoplasma bovis and Staph. aureus were both identi-
fied in 17 (3.5%) udder quarter milk samples. Strepto-
coccus agalactiae and Strep. uberis were identified in 
14 (2.9%) and 15 (3.1%) udder quarter milk samples, 
respectively.
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Elimination of Udder Pathogens During  
the Dry Period
Among detected udder pathogens, Strep. uberis had 
the highest elimination rate (100.0%). Elimination 
rates for M. bovis, Staph. aureus, and Strep. agalactiae 
were 86.7, 93.6, and 96.2%, respectively (Table 1).
Inflammatory Response in the Udder Quarters 
Before and After Dry Period
The milk Hp concentration was below the working 
range (≤60 mg/L) in 91 (17.8%) out of 510 udder quar-
ter milk samples at dry off. After calving, the milk Hp 
concentration was below the working range in 1.8% (n 
= 9) of 491 udder quarter milk samples. In 10 (2%) 
postpartum and 4 (0.8%) dry off udder quarter milk 
samples with blood, the milk Hp concentration ranged 
between 181 and 4,096 mg/L.
The milk Hp concentration was higher in milk sam-
ples positive for Strep. agalactiae at dry off compared 
with milk samples negative for Strep. agalactiae (Figure 
1). After calving, the milk Hp concentration was signifi-
cantly higher in milk samples with blood and in milk 
samples positive for Staph. aureus compared with milk 
samples without blood and milk samples negative for 
Staph. aureus (Figure 2).
DISCUSSION
Elimination of Udder Pathogens During  
the Dry Period
The aim of our study was to evaluate the elimina-
tion of 4 udder pathogens from infected udder quarters 
during the dry period in cows treated with cloxacillin 
at dry off. Because only 1 herd was used for our study, 
the results are not directly comparable to other farms 
Figure 1. Results of mixed tobit regression model (86 right-censored samples) of associations between udder quarter milk samples (n = 510) 
haptoglobin (Hp) concentration (mg/L) after 1/square root transformation (because of inverse transformation negative coefficient means posi-
tive effect) and udder pathogens at the dry off. Model confidence intervals are presented as horizontal bars. Point estimates for variables are 
shown on top of the bars. Cow lactation (compared with first-lactation dairy cows; n = 217) and DIM were retained in the model as confounders. 
Color version available online.
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with different management practices and use of dry cow 
antibiotic therapy.
We identified a high elimination rate (86.7%) for 
M. bovis during the dry period. Mycoplasma bovis is 
resistant to many antibiotics, including cloxacillin 
(Rosenbusch et al., 2005), and M. bovis IMI is usually 
considered untreatable with dry cow therapy (Ruegg 
and Erskine, 2015). Hence, the elimination of M. bovis 
during the dry period is probably caused by other fac-
tors, such as altered cow immunity or unsuitable con-
ditions for mycoplasma cells in dry mammary glands. 
Because of the small sample size, our results are only 
indicative, and further studies should investigate the 
elimination of M. bovis during the dry period in a larger 
study population.
Additionally, we identified a high elimination rate 
for Strep. agalactiae and Strep. uberis during the dry 
period, which is in line with previous studies (Dufour 
and Dohoo, 2013; Bradley et al., 2015). The elimina-
tion rate for Staph. aureus was also high in our study. 
The recovery from Staph. aureus IMI during the dry 
period is described to be more difficult compared with 
Strep. agalactiae IMI and to depend on the strain of 
Staph. aureus, with some strains of Staph. aureus being 
naturally more susceptible for elimination by antibiot-
Figure 2. Results of mixed linear regression model of associations between udder quarter milk samples (n = 479) haptoglobin (Hp) con-
centration (mg/L) after 1/square root transformation (because of inverse transformation negative coefficient means positive effect) and udder 
pathogens after calving. Model confidence intervals are presented as horizontal bars. Point estimates for variables are shown on top of the bars. 
Cow lactation (compared with first-lactation dairy cows; n = 216), DIM, and the length of dry period were retained in the model as confound-
ers. Color version available online.
Table 1. Elimination and new IMI rate in udder quarter milk samples 




New IMI  
rate,2 n (%)
Mycoplasma bovis 13/15 (86.7) 15/498 (3.0)
Staphylococcus aureus 59/63 (93.6) 13/450 (2.9)
Streptococcus agalactiae 127/132 (96.2) 9/381 (2.4)
Streptococcus uberis 23/23 (100.0) 15/490 (3.1)
1Number of negative udder quarter milk samples postcalving, positive 
at dry off/number of positive udder quarter milk samples at dry off.
2Number of positive udder quarter milk samples postcalving, negative 
at dry off/number of negative udder quarter milk samples at dry off.
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ics (Dingwell et al., 2006). We did not use genotyping 
methods for the characterization of the detected Staph. 
aureus, so we cannot draw any conclusions about the 
possible strain variation as a cause for the high elimina-
tion rate of Staph. aureus. An alternative explanation 
for the high elimination rate of Staph. aureus could be 
the parity of cows. A higher probability for elimination 
of Staph. aureus IMI during the dry period is described 
in cows with lower parity, that is with younger cows 
(Dingwell et al., 2006). In our study, most of the cows 
were in their first or second lactation, which may ex-
plain the better elimination rate of Staph. aureus dur-
ing the dry period.
A high sensitivity of the PCR method to detect udder 
pathogens from milk samples was reported in Koskinen 
et al. (2010). To our knowledge, ours is the first study 
in which commercial qPCR analysis was used to detect 
mastitis pathogens in quarter milk samples at dry off 
and after calving. However, we collected cow udder 
quarter milk samples only once before and after the 
dry period, which may have increased the probability 
of false-negative and false-positive test results. As cows 
do not excrete a steady number of bacteria with milk 
all the time, the amount of bacterial DNA in negative 
udder quarter milk samples may have been below the 
qPCR detection limit, giving false-negative results. On 
the other hand, a sensitive qPCR detects the bacterial 
DNA also from nonviable bacteria (Nyman et al., 2016; 
Parker et al., 2018). Hence, in our study some qPCR-
positive udder quarter milk samples may have been 
falsely positive due to bacterial DNA from bacteria 
already killed by the cows’ immune system. Repeated 
udder quarter milk sampling could have reduced the 
probability of false-negative and false-positive qPCR 
test results.
Cow udder quarter milk samples were analyzed with 
qPCR test kit detecting DNA of Strep. agalactiae, 
Staph. aureus, Strep. uberis, and M. bovis; therefore, 
we cannot draw any conclusions about the elimina-
tion of other udder pathogens. Pathogen-negative ud-
der quarter milk samples in our study may have been 
positive for other udder pathogens, such as CNS, which 
are not detected by qPCR test kit Mastitis 4B. Ad-
ditionally, this test kit detects udder pathogens at the 
species level; however, different strains of bacteria may 
circulate in the farm causing IMI. As we did not do any 
strain analysis, we cannot make any judgements about 
the variation in bacterial strains.
Inflammatory Response in the Infected Udder 
Quarters Before and After Dry Period
We evaluated milk Hp concentration in udder 
quarter milk samples at dry off and at first milking 
postpartum to find associations between the milk Hp 
level and the presence of detected udder pathogens in 
udder quarter milk samples. We found elevated milk 
Hp concentrations in milk samples positive for Strep. 
agalactiae at dry off and in milk samples positive 
for Staph. aureus after calving compared with udder 
quarter milk samples negative for these pathogens. 
Both Strep. agalactiae and Staph. aureus usually cause 
chronic subclinical mastitis (Keefe, 2012). Eckersall et 
al. (2006) found that experimentally induced subclini-
cal Staph. aureus IMI increased milk Hp concentration. 
In our study, elevated milk Hp concentration in udder 
quarter milk samples positive for Strep. agalactiae at 
dry off and for Staph. aureus postpartum may indicate 
a present or recent subclinical IMI caused by these ud-
der pathogens. Milk Hp may be affected by multiple 
udder pathogens, and the number of bacteria detected 
in our study was limited to 4 main gram-positive udder 
pathogens. Therefore, the milk Hp concentration in ud-
der quarter milk samples may have been affected by ud-
der pathogens not detected in the qPCR test kit used 
in our study. Further studies with larger sample size are 
needed to evaluate the association between subclinical 
udder inflammation and the milk Hp concentration, 
and the results of our study should be considered as 
indicative.
We did not find a significant correlation between the 
milk Hp concentration and the presence of M. bovis in 
udder quarter milk samples at dry off or after calving. 
To our knowledge, no published data exists about the 
presence of M. bovis in udder quarters and local inflam-
matory response in mammary gland measured via milk 
Hp concentration. Therefore, further studies are needed 
to understand the factors affecting milk Hp concentra-
tion in M. bovis-positive udder quarters.
CONCLUSIONS
The elimination of Strep. agalactiae, Staph. aureus 
and Strep. uberis during the dry period was high. The 
elimination of M. bovis during the dry period was lower 
compared with the elimination of Strep. agalactiae, 
Staph aureus, or Strep. uberis. Results of this study 
indicate that spontaneous elimination of M. bovis prob-
ably occurs during the dry period. However, further 
studies should investigate the elimination rate of M. bo-
vis during the dry period in a larger population. Higher 
milk Hp concentrations at dry off were identified in 
Strep. agalactiae-positive udder quarter milk samples 
compared with pathogen-negative udder quarter milk 
samples; the same association was found for Staph. 
aureus postpartum. We can conclude that the milk Hp 
concentration can be used as an indicator of the pres-
117
9338 TIMONEN ET AL.
Journal of Dairy Science Vol. 101 No. 10, 2018
ence of udder inflammation at dry off and after calving 
together with bacteriological results.
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